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Smart contact lenses (SCLs) are a new class of wearable medical device set to 
revolutionise the way we approach healthcare. SCLs have been designed for 
functions such as active vision correction, drug delivery, display technology and 
chemical sensing. By integrating electrochemical sensors into SCLs, continuous, 
unobtrusive and non-invasive monitoring of chemical markers in the tear film may be 
carried out. However, despite significant advances in the past few years, an 
electrochemical smart contact lens (ESCL) suitable for clinical use has not yet been 
demonstrated. There are still design challenges which need to be addressed before 
this technology matures into real medical utility. 
The primary issues facing ESCLs today are the construction of a safe, comfortable 
device, and the fidelity of the measurements made in the tear film when compared 
to an equivalent measurement in the blood. Recent advances in SCL platforms may 
be used to inform a new ESCL design, and address the issues of discomfort or safe 
use. A clinically approved SCL for glaucoma treatment is already used in hospitals 
around the world, offering hope of a clear path to an approved ESCL. However, the 
question of measurement fidelity may represent a greater challenge. 
In this thesis, a next-generation ESCL is designed, built and characterised. The 
physical design follows previous work towards soft SCL platforms, and represents a 
significant improvement on the current ESCL state-of-the-art. To improve the quality 
of the measurements taken in this device, advanced electrochemical sensors are 
first investigated and developed on flexible substrates suitable for SCL integration. 
In the final design, a set of spatially distributed, individually addressable 
microelectrode arrays are integrated into a soft ESCL. A new electrochemical 
method is also developed to perform video-rate spatiotemporal electrochemical 
sensing, with very low power requirements and a minimum of driving logic 
complexity. In addition, a neural network method is developed to correct for the 
measurement distortion inherent to taking measurements in the tear film and 
attempting to make conclusions about the equivalent measurement in the blood. In 
combination, this new design and methodology greatly improves both safety and 
comfort of the ESCL, and makes progress towards an ESCL capable of taking 
measurements continuously and unobtrusively with real clinical utility. 












Smart contact lenses are a new type of device used in medicine and healthcare. 
Usually consisting of contact lenses with electronics embedded inside, they can 
perform functions such as active vision correction (like refocussing and zoom), 
delivering drugs into the eye, or measuring substances in the tears. This thesis 
focusses on electrochemical measurements in the tear film, which is a common way 
to measure the concentration of certain chemicals. Measuring in tears can be a less 
invasive, more comfortable way to get information about health or to monitor a 
disease than doing blood tests. It also means you can measure continuously, and 
without requiring the patient to go to a hospital. This can reduce the burden on 
patients and on healthcare professionals. 
Although some smart contact lens prototypes have been made which can measure 
the concentration of chemicals such as glucose, they are not yet safe to use in the 
eye, and the measurements they make are not necessarily accurate enough to be 
useful to clinicians. The purpose of this thesis is to improve the design of the lens, 
the electrodes (i.e. the sensors themselves), and the way we make measurements, 
to be safer, more accurate, and to provide more information about what exactly is 
being measured. 
In this thesis, recent advances in smart contact lens design are adapted and 
improved upon to make a safer, more comfortable lens. Multiple sensors, with 
improved sensing performance, are built into the lens, and a new technique is 
developed which can not only measure the concentrations at different places in the 
eye, but at video-speed as well. With this, it will be possible to see when new tear 
fluid has entered the eye, and what the concentration is in the new fluid. This gives 
much more information about the concentration in the rest of the body than simply 
measuring the entire tear fluid at once. 
With these advances, safer, more accurate and more informative measurements 
can be made in the eye, leading to a smart contact lens with real use for healthcare 
professionals.  
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1.1 Wearable Devices and Non-Invasive Sensing 
The way we approach healthcare is undergoing a fundamental shift, driven by a new 
class of medical technology. Non-invasive systems such as smart contact lenses 
(SCLs) are designed to continuously and unobtrusively gather medical data while 
the wearer goes about their day, in order to monitor their health status or help make 
diagnostic assessments [1–4]. This approach represents a move from hospital-
based to distributed care, and has the potential to reduce the burden on hospitals 
and healthcare professionals, improve the quality of life of patients, and improve the 
quality and accuracy of the diagnostic conclusions we can make. 
The ability to make continuous measurements without interrupting a patient’s 
lifestyle has a number of significant advantages over individual tests, or even in 
comparison to continuous assessment in a hospital. When measuring the 
concentration of chemical biomarkers in the body, such as hormones or glucose, 
there is often a natural diurnal variation which is not accurately accounted for when 
individual ‘snapshot’ measurements are performed [5]. In fact, in many conditions 
the diagnosis rests on (or is aided by) tracking the time-series trend of an analyte, 
rather than the instantaneous concentration [6,7]. Diagnosing a disrupted cortisol 
response, for example, requires assessment of the elevation and return of the 
cortisol levels during the hours following an acute stressor [8]. Unobtrusive, multiple-
sensor measurement can also improve the quality of the data. Many analytes which 
may be used to make medical assessments are affected by lifestyle and mood; 
therefore something which may be stressful or unusual, such as a trip to the 
hospital, may significantly reduce the utility of a hospital-based measurement [9]. 
As the technology required to unobtrusively monitor and analyse a suite of analytes 
matures, the focus of healthcare may begin to shift from treatment to prevention. 
Diagnoses or warnings of declining health may be made earlier, potentially 
autonomously. In many diseases or conditions, early diagnosis can reduce 
treatment time and improve patient outcome, particularly in degenerative conditions, 
while active management of a healthy lifestyle can help a person avoid ill-heath in 






Figure 1.1: Non-invasive sensing devices. (a) Electronic tattoo for monitoring 
lactate in human perspiration. Adapted from [10]. (b) Smart contact lens 
designed for glucose monitoring in the tear film. Adapted from [11,12]. (c) 
Device designed for bacteria detection on tooth enamel. Adapted from [13]. 
A major class of non-invasive medical devices are those designed to continuously 
measure chemical biomarkers in one of several non-invasive media: usually sweat 
(Figure 1.1 a), tear fluid (Figure 1.1 b) or saliva (Figure 1.1 c) [4]. Chemical 
concentrations are most commonly measured electrochemically, although other 
methods (such as chromatography or colour-indicator devices) have been explored. 
The devices typically take the form of electronic ‘tattoos’ (sweat) [10,14], smart 
contact lenses (tear fluid) [2,3,15,16], and mouthguard or on-tooth sensors (saliva) 
[13,17]. While there is a degree of similarity among the function of these devices, 
each class of non-invasive media presents its own design challenges. 
Of these media, tear fluid may offer the widest range of potential applications and 
benefits. Saliva, although a useful sensing medium, faces the challenge of 
unpredictable chemical interference from food and drink, as well as issues of patient 
compliance. And, while sweat-based sensing is similar in method to tear-based 
sensing, and skin-mounted electronics cause minimal discomfort, the skin is a highly 
effective barrier to chemical markers from the blood and the sweat does not provide 
a faithful representation of concentration in the blood in many cases; in general, 





and calcium sensing [4]. Conversely, the tear film contains a suite of biomarkers 
which show good correlation to the concentration found in the blood (Section 1.1.5). 
Contact lenses can also be worn by most users with little or no discomfort, and are 
largely protected from damage within the eye, while saliva or on-skin ‘tattoo’ sensors 
may easily be damaged during normal use. 
For these reasons, SCLs have been the subject of significant research in recent 
years, and represent a promising class of device for continuous, non-invasive 
sensing. Electrochemical smart contact lenses (ESCLs) have been developed 
alongside SCLs designed for active vision correction [18,19], intra-ocular pressure 
monitoring [20,21], visual or indicator displays, drug delivery [22], and more [23]. An 
additional benefit of the SCL platform is that multimodal devices may be created 
which incorporate a number of these functionalities into one device [15]. Finally, 
there exists an established contact lens industry, which provides two significant 
benefits: the physical parameters and fabrication of the supporting structure is 
already well characterised; and the idea of (and infrastructure catering to) wearing a 
contact lens is already normalised in the public consciousness. 
1.2 Design Criteria of Smart Contact Lenses 
A smart contact lens inherits the design parameters of a passive contact lens; that 
is, it must satisfactorily fulfil the safety and comfort requirements of a clinically 
approved lens before additional function is considered. There are two main types of 
contact lenses: rigid gas permeable (RGP, or gas permeable, GP), and soft lenses. 
Soft contact lenses are the most commonly used class of contact lens, and account 
for approximately 90% of wearers in the USA [24]. 
Soft contact lenses are usually made from hydrogel, with modern designs frequently 
incorporating silicone, while GP lenses are made from porous polymer, usually also 
incorporating silicone in order to improve flexibility and comfort [25]. They are 
typically around 14 mm in diameter, with a hemispherical inner (corneal) curvature 
of 8 - 10 mm [26]. Lens thickness usually varies from 60 - 240 µm, depending on the 






When adding functionality to a contact lens, additional design constraints must be 
followed. The mechanical properties of the contact lens platform must be matched 
as closely as possible by all integrated components; therefore flexible substrates 
must be used during fabrication. Ideally all materials, but at least any non-
encapsulated materials, should be biocompatible to prevent a foreign body response 
and protect the eye from damage.  
If on-board circuitry is required, this must ideally remain within the thickness 
constraint above, although a lens of central thickness 600 µm has been used with 
no reported irritation [28]. In most prototypes a thinned silicon chip has been 
incorporated, which can be reduced to a thickness of some tens of microns [29]. 
Thinned silicon is somewhat flexible, but with an elastic modulus of greater than 
160 GPa in the <110> crystalline direction [30] it is much stiffer than the materials 
used in soft smart contact lenses (e.g. polyimide, with an elastic modulus of 2.5 GPa 
[31]); hence, to avoid irritation or damage in the eye, the footprint of this chip must 
remain small (approx. 1 mm2). 
Table 1.1: Design criteria of a smart contact lens 
Design Criteria Specification Ref 
Thickness 60-240 µm (ideal); <600 µm (upper range) [26,27] 
Diameter 14 mm [26] 
Radius of curvature 8-10 mm [26] 
Transparency Central 8 mm ⌀ [112] 
Flexibility -  
O2 permeability Daily: 24.1 x 10
-9 cm s-1 [mm Hg]-1 
Extended wear: 
34.3 x 10-9 cm s-1 [mm Hg]-1 
[113] 
Power consumption Approx. 100 µW [23] 
Data transfer Low bitrate [3] 
Biocompatibility Biocompatible materials or safe 
encapsulation 
[82] 
Waterproofing Electronic components protected from 
ingress of water 
- 








The pupillary region (a central portion of the lens of maximum diameter 8 – 9 mm) 
must be (predominantly) transparent to avoid impeding the wearer’s vision. Oxygen 
permeability is also crucial for ensuring sufficient oxygenation of the eye. Modern 
contact lens materials are highly oxygen permeable [32], but most flexible, 
transparent substrates used in sensor fabrication or flexible electronics in general 
are not. If the lens is to be worn for extended periods, oxygen flow must be ensured, 
either by reducing the total area utilised by non-oxygen-permeable materials, or by 
developing new substrates which allow oxygen transmission. 
In addition to user comfort and safety, there are some environmental factors which 
must be considered to ensure reliable function of the device. The eye is an aqueous 
environment, and the system within the lens must be protected from ingress of water 
by suitable encapsulation. It must be robust to repeated mechanical deformation, in 
particular folding of the lens, as this is a common mode of use when inserting or 
removing a contact lens. Most SCL prototypes aim to function wirelessly, and since 
battery technology is not quite yet advanced sufficiently to produce a safe, flexible 
battery of sufficient capacity for extended use (although advances in this field have 
recently been reported [33]), other power sources are usually utilised. 
Supercapacitors and fuel cells have been suggested [34], but currently the most 
promising method is to use an antenna in the SCL to harvest power inductively from 
a radio frequency source (delivered from an eye-patch or glasses frames) [3]. A 
benefit of this method is that an antenna can also be used for data transfer, which, 
due to the extremely limited storage space in a SCL, is necessary for harvesting 
continuous data. Due to limits placed on the safe level of RF radiation into the eye, 
power transfer is limited [35]; power transfer on the order of 100 µW has been 
demonstrated [23], and the entire system must function on this power allowance. 
Data transfer is also limited, and therefore in designing the system as a whole it is 
important to be discerning about the quantity of data both produced and harvested. 
1.3 Measurement of Chemical Markers 
A common method of chemical sensing in point-of-care devices is electrochemical 
sensing [36]. There are a number of benefits to this technique over other methods 
such as NMR, mass spectrometry, and chromatographic or electrophoretic 
separation. First, the infrastructure is easily miniaturised by microfabrication 
methods. The system can be solid-state, and in many cases requires no prior 





amplification and a linear operation to produce concentration values from measured 
current), and can operate on a low-power basis (drawing approx. 10-8 W, or less if 
required [16]). Chemical or biochemical functionalisation methods can make the 
sensors selective for a large variety of different chemical species [37]. Finally, the 
methodology is well characterised, and, particularly as a result of developments in 
glucose monitoring technology, significant effort has already been directed towards 
optimised production of small, point-of-care electrochemical systems which require 
no expertise for use [38]. 
 
Figure 1.2: Electrochemical methods. (a) Schematic circuit of a three-
electrode system, often used to carry out chronoamperometry and cyclic 
voltammetry. (b) Overview of the chronoamperometric method: (b.i) 
waveform of voltage step experiment in which species is electroinactive at 
E1, but reduced at E2; (b.ii) concentration profiles for various times during the 
experiement; (b.iii) Current flow versus time. (c) Overview of the cyclic 
voltammetric method: (c.i) cyclic potential sweep; (c.ii) current flow versus 
time, also known as a cyclic voltammogram. Figures sourced from [39]. 
Various electrochemical methods exist. Most utilise a three-electrode system, with a 
working electrode (which may be functionalised for selectivity of a particular 
analyte), a counter electrode (which supplies current) and a reference electrode 
(against which the voltage may be measured) (Figure 1.2 a) [39]. Common methods 
include chronoamperometry (Figure 1.2 b), in which voltage is stepped from one 
value to another and the current is measured against time, and cyclic voltammetry 
(Figure 1.2 c), in which the voltage is swept between two limits while current is 
measured against voltage. 
Electrochemical sensing makes use of the fact that redox (reduction/oxidation) 
reactions occur spontaneously at a well-defined potential. Thus, by sweeping the 





the counter and working electrode, features of the current in the forward and 
backwards sweeps will correspond to the oxidation and reduction of target species 
in the medium. The magnitude of this current contains information about the 
concentration of the species within the medium. 
Some target analytes, such as ferrocenemethanol (FcMeOH), naturally undergo a 
redox reaction at a bare gold or platinum electrode at well-characterized potentials. 
These are frequently used as ‘redox reporters’, for characterisation and testing of 
electrochemical systems [40–42]. Other target analytes require intermediate 
chemical reactions to interface with the working electrode, usually functionalizing the 
electrode surface to select for a specific chemical, though immobilization of active 
chemical modifiers in hydrogel or solution is also used [37]. For example, 
electrochemical sensing of glucose uses the glucose oxidase (GOx) enzyme, 
usually immobilised on the working electrode surface using thiol groups [43], which 
turns over glucose in the presence of oxygen to form hydrogen peroxide [38]. 
Hydrogen peroxide then oxidises at the working electrode under an anodic current, 
and the current resulting from this oxidation is measured by the electrochemical 
system: 
         GOx 
glucose + O2 → gluconic acid + H2O2     (1.1) 
H2O2 → O2 + 2H+ + 2e- .       (1.2) 
The physical design of the working electrode has a significant effect on the sensing 
properties of the electrochemical system [44–47]. Working electrodes with at least 
one relevant dimension of less than 100 µm are generally classed as 
microelectrodes, while those with a relevant dimension less than 100 nm are 
classed as nanoelectrodes. Micro- and nanoelectrodes have enhanced sensing 
properties when compared to macroelectrodes, because at smaller length scales a 
radial diffusion field is formed around the microelectrode, while a predominantly 
linear diffusion field is formed around a planar macroelectrode (Figure 1.3) [47]. 
Radial diffusion is more spatially efficient in terms of current density and analyte flux, 
and, since noise scales with electrode area, leads to an improved limit of detection 






Figure 1.3: Diffusion characteristics of macro- and microelectrodes. (a) 
Predominantly linear diffusion field formed during operation of a 
macroelectrode. (b) Predominantly radial diffusion field formed during 
operation of a microelectrode array. 
After a certain time, growth of the individual radial diffusion fields supplying each 
microelectrode in a microelectrode array will lead to overlap, and a predominantly 
linear diffusion field is formed form the combination of the sub-fields. After this time, 
the microelectrode array acts akin to a macroelectrode of equivalent areal size, and 
the advantageous sensing properties of microelectrodes are lost. 
During electrochemical measurements a double layer capacitance is charged at the 
electrode surface [39,48]. This capacitance is proportional to electrode area, and 
hence charges faster for smaller electrodes. Thus, the speed at which 
measurements may be taken is also improved in micro and nanoelectrodes. 
Miniaturisation of the working electrode reduces the magnitude of current drawn 
during measurement, which reduces power requirements of the system [49]. If the 
current is too low, specialised potentiostats or amplifiers may be needed to process 
the signal, but the advantageous sensing properties of miniaturised electrodes may 
be preserved while drawing a higher current by using multiple connected micro- or 
nanoelectrodes and operating them in summation [16,47]. These are often termed 
micro- or nanoelectrode arrays [50], and are distinct from arrays of individually 





1.4 Eyes and the Tear Film 
 
Figure 1.4: The tear film and lachrymal system. (a) Schematic representation 
of the bilayer model of the tear film. (b) Illustration of the anatomy of the 
lachrymal system surrounding the eye. Reproduced from Gray's Anatomy, 
Plate 896. 
The tear film is a complex fluid environment. Current estimations of the thickness of 
the tear film range from 3 – 11 µm, and the leading model suggests a bi-layer 
structure, with a thin superficial lipid layer and an aqueous/mucin gel layer with 
decreasing mucin content from the corneal surface to the lipid layer (Figure 1.4 a) 
[51]. Lachrymal fluid enters the eye from the lachrymal gland at the upper lateral 
region, and flows across the cornea to the superior and inferior lachrymal puncta, 
through which it drains into the lachrymal sac and subsequently into the naso-
lachrymal duct (Figure 1.4 b). While the flow of lachrymal fluid has been studied, the 
flow of the tear film over or underneath a contact lens is not as well characterised 
[51–54]. 
There is also a difference in chemical composition between ‘basal’ tears (with which 
the cornea is kept continually wet and nourished), ‘emotional’ tears (triggered by 
strong emotional responses), and ‘reflex’ tears (stimulated by irritation to the eye) 
[55,56]. Reflex tears generally contain different quantities of the chemical analytes 
found in the blood when compared to the other two categories. It is therefore crucial 
that an ESCL does not irritate the eye when performing measurement. Other 
methods of harvesting tear fluid for analysis [57] often require skilled application to 





found less of a correlation between analytes in the tear film and blood than more 
recent studies [58–60]. 
Performing electrochemical measurements in the eye is therefore not as simple as 
placing a single electrode in an ESCL and assuming a direct or lag/bias relationship 
between the measurements performed there and the concentration in the blood [7]. 
In fact, there is a series of effects which combine to create a complex measurement 
distortion, and this must be corrected for if we are to make accurate diagnostic 
conclusions from electrochemical measurements performed there. In addition, due 
to variations in physiology all of these effects are patient-specific (i.e. each patient 
will exhibit a unique measurement distortion). These effects are: 
1. The metabolic pathway of the analyte from the blood plasma to the lachrymal 
fluid; 
2. Filtration into the eye via the lachrymal gland at various rates depending on 
eye stimulation, hydration etc; 
3. Mixing of fresh tear fluid with existing fluid in the tear film and lachrymal lake 
(an indeterminately mixed bulk of tear fluid situated at the lower eyelid); 
4. Increased concentration of analyte due to evaporation, and; 
5. Egress of analyte through the lachrymal puncta, crying, or other pathways. 
In order to correct for the overall measurement distortion in electrochemical 
measurements performed in the tear film (or other non-invasive media), a 
multimodal approach is necessary. Design of an ESCL which provides data on the 
introduction, progress, mixing and drainage of tear fluid in the eye would provide 
more information about the nature of the sensing medium in which measurements 
are taking place [16,49]. With this information, more accurate conclusions about the 
concentration levels in the in-flowing lachrymal fluid may be made, which would both 
increase measurement accuracy and reduce the time delay in sensing concentration 
changes in the blood. A patient-specific method to perform a mathematical 
correction for the distortion between concentration in the lachrymal fluid and the 
blood would address the remaining source of measurement distortion, and account 
for the individuality of each patient’s physiology. 
1.5 Analytes 
 A number of different analytes have been proposed as good candidates for non-





is glucose monitoring, due to the established industry around diabetes management 
[15,58,62]. There are already numerous methods for glucose monitoring, with point-
of-care devices such as handheld fingerprick sensors and minimally-invasive 
continuous glucose monitors (CGMs), which monitor glucose in the interstitial fluid 
(ISF), being the most common [38]. Both of these methods require puncturing the 
skin, either to draw blood (in the fingerprick method) or to provide constant access 
to the ISF (for transdermal or subcutaneous CGMs). Monitoring glucose in the tear 
film with an ESCL would most likely represent an improvement in patient comfort 
when compared to these methods. However, the nature of diabetes management, in 
which an early-warning system is often essential, calls into question the suitability of 
SCL-based diabetes monitoring; there is a significant time delay between blood 
glucose concentration and its representation in the tear film [58]. CGM methods 
already provide many of the benefits which would be derived from an ESCL, and the 
drawbacks (the time delay) potentially outweigh the additional improvements (the 
improved comfort of a non-invasive device). It is currently unclear whether 
measurement distortion correction methods would be able to sufficiently reduce this 
delay in order to use an ESCL for diabetes management (Chapter 5). However, 
many other analytes exist with potential diagnostic utility; Table 1.2 details some of 
these analytes and their diagnostic application.  
Lactate is a metabolite found in the tear film which may be used as a marker of 
ischemia, sepsis, liver disease and cancer [2]. It is frequently measured in 
diagnostic scenarios, and also in assessing athletic performance, but there is 
currently no satisfactory way to monitor it continuously. Lactate may therefore be a 
promising candidate for ESCL-based measurement. Like glucose, a 
functionalisation method for selectivity of the L-lactate molecule is well described, 






Table 1.2: Biomarkers found in the tear film and their diagnostic 
applications. Some parts adapted from [11]. 
Analyte Diagnostic Application Ref 
Glucose Diabetes management [114] 
Lactate Ischemia, sepsis, liver disease and 
cancer 
[2] 
Na+ Hyper/hyponatremia [115] 
K+ Hyper/hypokalemia and ocular 
disease 
[116] 
Ca2+ Hyper/hypocalcemia [117] 
Mg2+ Hyper/hypomagnesemia [118] 
Cl- Hyper/hypochloremia [119] 
Urea Renal function [120] 
Pyruvate Genetic disorders of mitochondrial 
energy metabolism 
[121] 
Ascorbate Diabetes [122,123] 
Total Protein Dry eye conditions, ocular insult and 
inflammation 
[124,125] 
Alcohol Intoxication [126] 
Vitamins (B2, C, B6) Nutrition [126] 
Dopamine Glaucoma [72] 
Cortisol Stress-related illnesses, Cushing’s 
disease, Addison’s disease 
[9,67] 
Serotonin Alcoholism, mood and sleep disorders [67] 











Figure 1.5: Cortisol variation throughout the day and after an acute stressor. 
(a) 24 hour plasma cortisol secretion curve in humans. Adapted from [5]. (b) 
The effect of repeated stressors on cortisol response. Physiological 
adaptation to repeated stressors (chronic stress) can lead to disrupted 






Other markers which may be of relevance in ESCL sensing include urea, which is 
an indicator in kidney health [63], metal ions such as Na+, K+, Ca2+, Mg2+, Cl- and 
HCO3- for elevated or reduced levels outwith healthy ranges [11] and more. 
Electrochemical methods have also been developed to measure hormones such as 
cortisol, dopamine and serotonin [64–66], and studies have found good 
representation of blood levels in the tear film [67]. Continuous, unobtrusive sensing 
is of particular importance in assessing underlying physiological processes, such as 
the response of the endocrine system, in conditions which have a psychological 
element. For example, a disrupted cortisol response to an acute stressor 
(Figure 1.5) is a diagnostic indicator in conditions such as depression [68,69], 
chronic stress [8,9], addiction [5], PTSD [70] and more, and there is currently no 
satisfactory way to monitor cortisol continuously and unobtrusively, such that the 
measurement itself does not influence the result. Non-invasive technology such as 
ESCLs may provide valuable new insights into conditions in which we better 
understand the psychological effects than the physiological, and would be a vast 
improvement on the current practice (a twice-daily saliva swab) [16]. In addition, 
hormones can act as biomarkers for various ocular conditions, such as serotonin 
and dry-eye [71] or dopamine and glaucoma [72]. 
The tear film also contains a wide range of proteins, electrolytes and lipids, and the 
diagnostic potential of many of these is yet unexplored [73,74]. Additionally, ESCLs 
could be used to monitor drug or alcohol levels in the body, or to help quantify 
uptake of drugs delivered via the eye. 
1.6 Outline of the Thesis 
1.6.1 Key Objectives and Expected Outcomes 
The aim of this PhD is to develop a next generation ESCL device, incorporating the 
following improvements on the current state-of-the-art: 
1. Improved sensors: advanced micro- and nanoelectrodes will be fabricated on 
SCL-compatible substrates, and their physical and electrochemical 
properties characterised. Multiple individually-addressable microelectrode 
arrays will be integrated into a SCL, making use of the enhanced sensing 
characteristics of microelectrodes, and gathering more information about the 





2. Improved platform: the microelectrode system will be integrated into the 
polyimide/TPU platform developed at Ghent University, building upon 
established work and providing a route to clinical use. A new ESCL, 
incorporating microelectrode array technology, will be designed, fabricated 
and characterised. 
3. Improved data processing: with a clearer understanding of the challenges 
faced in gathering meaningful electrochemical data in the eye, the physical 
design will be combined with new data processing methods to address the 
issue of measurement distortion in ESCLs and non-invasive devices in 
general. 
1.6.2 Thesis Overview 
Chapter 1: Introduction 
An introduction, including an overview of research scope and context, key methods 
within the field of electrochemistry, relevant information on ocular and diagnostic 
physiology, and material and physical design of (smart) contact lenses. 
Chapter 2: State of the Art 
An overview of the state of the art in SCLs, ESCLs and other relevant technologies. 
Chapter 3: Spatiotemporal Sensing on a Flexible Microelectrode Array 
A study into integration of microelectrode arrays onto flexible polyimide substrates is 
made. Eight individually addressable microelectrodes, with an integrated counter 
electrode, are fabricated on polyimide. The flexible microdisc electrodes are 
characterised physically and electrochemically. A new spatiotemporal 
electrochemical method is introduced. 
Chapter 4: Flexible Through-Flow Ultramicro and Nanoband Electrodes 
A study into a new laser-based fabrication method for ultramicro and nanoband 
electrodes on flexible polyimide substrates is made. Electrode morphology and 
performance are characterised, and use cases are explored, including robustness of 
the device under extreme mechanical deformation and damage, and active 
electrochemical sensing of through-flowing liquids. 





The issue of measurement fidelity in non-invasive sensing, and in particular in 
ESCLs, is formulated and placed in the wider context of medical diagnostics and 
measurement. A novel approach for measurement correction using neural networks 
is described, and a preliminary demonstration is made using two types of data. The 
neural network technique is compared quantitatively to the lag/bias correction 
method widely used in glucose sensing. 
Chapter 6: Spatiotemporal Electrochemical Sensing in a Smart Contact Lens 
An ESCL prototype comprising four individually addressable microelectrode array 
islands, and an integrated counter electrode, is designed, fabricated, and 
characterised, both physically and electrochemically. Various new design and 
fabrication solutions are presented. An updated version of the spatiotemporal 
electrochemical sensing technique is described, and the system is tested in various 
representative environments, including a model eye, generating a time- and space-
varying concentration map across the surface of the model eye. 
Chapter 7: Summary and Conclusions 
The work is summarised, and achievements are placed in the context of the 
research field. Conclusions are made and future work is proposed, including further 
integration work to prepare a device for clinical trials, design improvements to the 
ESCL prototype, and functionalisation work to address specific biomarkers in an 
ocular environment. 
  




2 State of the Art 
2.1 Smart Contact Lenses in Research and Clinical Use 
 
Figure 2.1: The Sensimed Triggerfish, a SCL in clinical use. (a) The 
Triggerfish lens. (b) The Triggerfish in use, with the eyepatch and power/data 
storage unit shown. Adapted from [75,76]. 
Smart contact lens concepts and prototypes have been found in a range of different 
research fields, in the media, and in clinical use. An FDA approved SCL designed 
for glaucoma treatment is currently used by clinicians (Figure 2.1 a) [21,75,76]. This 
device uses a strain gauge to monitor intra-ocular pressure, and contains a thinned 
silicon chip and a gold antenna to harvest power inductively from a patch worn 
around the eye (Figure 2.1 b). 
In their representation by the media, many contact lens prototypes appear centred 
around augmented reality, virtual reality, and embedded camera technology. 
However, the research field does not reflect this distribution. Significant work has 
been focussed on integration of liquid crystal displays (LCDs) into contact lenses 
[18,19], usually for active vision correction such as electronic focussing or 
magnification, or to create an artificial iris. Single element LED indicators have also 
been integrated into SCLs, with the potential to warn the user or others in the case 
of (e.g.) a hypo- or hyperglycemic event [23]. Other SCL designs with drug delivery 
technology have been proposed [22]. 





Figure 2.2: The first published wireless ESCL prototype. (a) Side view, 
adapted from [1]. (b) Top view, adapted from [62]. 
Electrochemical sensing in SCLs has been reported in a number of different studies. 
The first ESCL prototypes were developed at the University of Washington (Figure 
2.2), culminating around 2012 in a series of wireless devices functionalised to 
measure glucose or lactate [2,3]. Platinum electrode sites were defined on a 
polyethylene terephthalate (PET) substrate, and then cut and moulded in a 
hemispherical lens shape. A silicon chip integrated into the SCL platform carried out 
power harvesting, electrochemical measurement, signal processing and data 
transfer. The concentration measured was encoded into a frequency shift in the 
reflected signal from the antenna. 





Figure 2.3: Schematic representation of a more recent ESCL design 
representing a departure from traditional metal deposition fabrication 
methods. Adapted from [77].  
Since then, studies have explored other methods of fabricating glucose sensors in a 
SCL; for example, a graphene/AgNW (silver nanowire) hybrid was used to create 
transparent, stretchable components, and functionalised a section with GOx for 
glucose sensing (Figure 2.3) [77]. A similar functionalisation method was also used 
to create a graphene-based glucose sensor in a soft contact lens [15]. Both of these 
advances succeeded in developing unconventional fabrication methods which led to 
transparent and stretchable structures, although they did not necessarily aim to 
improve the quality of the electrochemical measurement itself. 
2.2 Fabrication Methods and Material Design 
At the intersection of the design constraints discussed in Section 1.1.2, and the 
fabrication processes necessary to create electrochemical sensors, there is a 
relatively narrow choice of well-studied substrates for SCL platform design. Many 
prototypes used a PET substrate [3], due to its biocompatibility, transparency, 
resistance to many of the chemicals used in cleanroom processing [78], and low 
glass transition temperature of around 60 - 65 °C [79], which allowed thermoforming 
after fabrication. However, PET substrates exhibit buckling behaviour after 
thermoforming [80], and are not sufficiently oxygen permeable to ensure safe 
extended use (with diffusivity on the order of 10-19 m2 s-1 [81]). Their low glass 
transition temperature also leads to issues in higher temperature cleanroom 




processes. Silicone or other elastomers and polymers [15,77] have been used to aid 
fabrication, though these reports do not always define a clear path to integration into 
a hydrogel-based soft contact lens. 
 
Figure 2.4: The SCL platform developed by Vásquez Quintero et al. at Ghent 
University [19]. (a) Core polyimide device, before chip integration and 
encapsulation into thermoplastic polyurethane (TPU); (b) schematic cross 
section of the core polyimide platform. (c) Soft SCL platform, ready for 
integration into hydrogel lens; (d) schematic cross section of the soft SCL 
platform. Adapted from [82]. 
A state-of-the-art SCL platform has been developed by Vásquez Quintero et al. at 
Ghent University for integration of LCDs, based on polyimide and thermoplastic 
polyurethane (TPU) (Figure 2.4) [19]. Polyimide is a biocompatible polymer [83,84] 
which is well-suited to cleanroom fabrication due to its resistance to chemicals, 
liquid-state processing, resistance to many chemicals used in cleanroom processing 
[78], and (after curing) its high glass transition temperature of 360 °C [85]. Layers of 
a few microns in thickness can be created, which leads to excellent flexibility. Due to 
these favourable properties, polyimide has been increasingly used in research 
towards flexible electronics intended for biomedical use [49,82,86–88]. The core of 
the platform creates metallization layers deposited between two layers of polyimide. 
This places the thin-film circuitry in the neutral mechanical plane of the device, 




which protects it from stress during mechanical deformation. Integration into this 
platform of a thinned silicon chip (30 µm thickness, approx. 0.2 mm2) has been 
demonstrated (Figure 2.4 c). 
The core of the device is encapsulated in TPU, which can then be thermoformed 
into a hemispherical cap shape. TPU is also a biocompatible polymer [89], and can 
be moulded at temperatures below 150 °C [19]. A laser is used to define the 
physical structure of both the core device and the TPU encapsulation, ensuring the 
minimum footprint of non-oxygen-transmissible structures within the lens. The final 
device can be integrated into a hydrogel to create a soft SCL. 
 
Figure 2.5: Wrinkling and buckling behaviour of PET substrates after 
thermoforming into a spherical cap shape. Reproduced from [80]. 
A recurring issue when integrating electronics into a contact lens platform has been 
buckling behaviour observed in the substrate after thermoforming [80]. SCL 
prototypes fabricated on PET and moulded to a hemispherical cap shape exhibit 
buckling (Figure 2.5) which could lead to discomfort and irritation in the eye, and 
accumulation of proteins and biofouling. The polyimide/TPU-based platform 
developed by Vásquez Quintero et al. [19] eliminates buckling behaviour by careful 
design of the polyimide/TPU regions (Figure 2.4 c); the polyimide regions are not 
stretchable, such that the metallization is protected within the neutral mechanical 
plane of the layer stack, while the TPU encapsulation is both stretchable and 
mouldable. Use of meanders in the radial direction and thin straight wires in the 
circumferential direction creates a flexible soft contact lens without buckling. 




Power harvesting architecture, such as on-board antennas, and chip integration 
have both been demonstrated in various platforms [3,23,28]. Antenna fabrication 
utilises the same fabrication pathway as metal-layer interconnects, as does chip 
placement, in which a bump-bonding method is used [90]. A design has also been 
demonstrated which functions without on-board signal processing, relying on 
externally-driven resistance-varying sensors which passively transduce a signal into 
a modulation of the device’s resonant frequency, as part of a RLC circuit [77]. 
Techniques such as this, in which some aspects of the measurement quality is 
sacrificed for the benefit of low-infrastructure operation, may represent crucial 
innovations for the shift towards unobtrusive sensing devices. 
Micro- or nanoelectrodes are usually fabricated in a cleanroom using standard 
silicon processes (primarily photolithographic steps) [47]. Metallization layers, often 
gold or platinum, are deposited, patterned, and passivated with an insulating top 
layer. Vias are created through the insulating layer to expose the metal layer at the 
electrode sites. Methods have been developed to adapt this fabrication process to 
flexible substrates including polyimide [49,82,86–88], where a polyimide layer is 
often used as both the primary substrate and the insulating top layer. However 
(before this thesis), integration into an SCL platform, and in particular a platform with 
an established route to clinical use such as that demonstrated by Vásquez Quintero 
et al. [19] had not yet been demonstrated [16]. 
ESCLs face a particular challenge: the sensing sites must be in contact with the tear 
film in order to operate. Therefore, during each encapsulation step, consideration 
must be given to how the electrochemical sensor will remain in contact with the 
lachrymal fluid. Current designs are not encapsulated in hydrogel or silicone, and 
although rigid non-gas permeable lenses are workable in a research setting, safe 
extended use is not possible without suitable encapsulation. Possible methods to 
achieve sensor access include: 
1. Windows may be created in each layer of the encapsulation to expose the 
sensing sites. A potential risk of this method is accumulation of proteins and 
lipids in the sensing sites, leading to biofouling and reduced sensing 
performance. This issue is of particular relevance to devices intended to be 
used for multiple days (as opposed to disposable ‘daily’ lenses). An 
overnight cleaning process may be able to alleviate some negative effects of 
biofouling. It is also possible that a window in the surface of the lens would 




cause irritation at the cornea, depending on its size and shape, if the sensors 
are in- rather than out-facing. 
2. Microfluidic channels may be created in the lens which draw tear film into the 
sensors and out after sensing. A blinking-mediated pumping method akin to 
muscolovenous pumping [91] could improve fluid flow. However, this would 
significantly increase the complexity of device fabrication, and biofouling of 
the channels could cause reduction in fluid transport. 
3. Hydrogel materials which allow sufficient transport of the sensing species 
may be used, or hydrogels with active functionalisation may act as a part of 
the sensor itself [92]. 
Current ESCL designs use a single electrochemical sensor for a particular analyte 
(in one case including a second working electrode to act as a differential sensor [3]). 
The result of this is that they most likely make electrochemical measurements within 
the lachrymal lake, an indeterminately mixed fluid. Without considering the 
introduction, flow and drainage of tear fluid across the eye, the measurements these 
devices make contain a large degree of uncertainty about the nature of the fluid they 
are measuring. However, studies so far have only investigated sensor performance 
in the ocular environment in the broadest sense, demonstrating a qualitative 
response but with no benchmark of fidelity to the underlying concentration in the 
blood [15,77]. 
In addition, electrode designs in ESCLs have been of a somewhat undefined 
geometric form [1,2,15,77], generally following manufacturing constraints or tradition 
rather than innovating to suit the SCL environment. While these sensors are 
sufficient for qualitative analysis of bulk changes in concentration, the enhanced 
sensing properties of microelectrodes would lead to better accuracy and detection 
limit, more efficient use of power and space, and faster sensor response. A number 
of microelectrodes may be integrated into a single device, either to generate spatial 
information about the concentration distribution across the eye, to measure various 
different analytes in a single device, or both [16]. 
  









3 Spatiotemporal Sensing on a Flexible Microelectrode 
Array 
 
Microelectrodes have a number of enhanced sensing properties when compared to 
macroelectrodes, which are of significant benefit to electrochemical measurement in 
the eye. They are also more spatially efficient, and draw less power, which makes 
them a promising class of electrode for SCL integration. Designing microelectrodes 
which can be integrated into the polyimide/TPU SCL platform developed by 
Vásquez Quintero et al. at Ghent University leverages state-of-the-art research in 
both microelectrode technology and material design in order to accelerate towards a 
clinically viable device. 
The first step towards integration of microelectrodes into the polyimide/TPU SCL 
platform is to create a microelectrode device using the core polyimide substrate. In 
this way, the first stage of the fabrication process can be investigated, and the 
electrochemical methods developed and characterised, before further integration 
steps such as moulding and encapsulation are undertaken. In this chapter, the 
design, fabrication and characterisation of an 8 x 1 linear array of individually 
addressable microelectrodes built on a polyimide platform is described, and a new 
spatiotemporal electrochemical sensing method is demonstrated. 
This chapter presents work some of which has been published in peer-reviewed 
articles [49,82]. 






Figure 3.1: Design of the flexible microelectrode device. (a) Schematic top 
view of device, with inset showing a single microelectrode site. (b) Schematic 
cross-section of a microelectrode site. Dimensions not to scale.  
An 8 x 1 linear array of individually addressable working electrodes was designed, 
with a set of common (shared) counter electrodes which are located such that each 
working electrode is proximal to a counter electrode site (Figure 3.1 a). The working 
electrodes are circular in shape (diameter 30 µm, located at the centre of a square 
pad, Figure 3.1 a inset. This form of electrode is termed a microdisc electrode), 
while each counter electrode site is rectangular (side lengths 450 µm, 950 µm). The 
device consists of a layer of gold (60 nm thickness, with an adhesion layer of 
titanium, 40 nm thickness) sandwiched between two layers of polyimide, both 
5.5 μm in thickness (Figure 3.1 b). Previous work on a polyimide/TPU-based SCL 
platform by Vásquez Quintero et al. [19] determined that meandering connections 
for wires travelling in the radial direction of the lens helped eliminate buckling 
behaviour. Therefore, meandering connections were used in this device, following 
the optimal design characteristics described in Verplancke et al. [93], to investigate 
the effect of using meandering instead of straight wires. Connection pads were 
designed to fit in a zero insertion force (ZIF) connector with 1 mm pad spacing. As 
the finished device is only 11 µm in thickness, a paper spacer was necessary to 
avoid movement in the connector. The shape of the device was chosen to maximise 
connector to electrode path length (in order to enable easier separation of liquid 




sensing media and connecting electronics), while also maximising number of 
devices fabricated on each 50 mm x 50 mm glass wafer (3 devices). 
 
Figure 3.2: Images of the flexible microelectrode device. (a) Photograph of 
the flexible microelectrode array; the positions of working electrodes W1-8 
are indicated. (b) Photomicrograph of one working electrode; the 30 μm 
diameter disc is situated in the centre of the square. The gold serpentine 
connections are visible through the transparent polyimide surface. (c) 
Photomicrograph of one part of the counter electrode; electrical connection is 
shared among all counter electrode sites. 
Vias in the top polyimide layer expose the gold layer at the electrode sites and 
contact pads; therefore the fabrication method results in the working electrodes 
being recessed by a depth of 5.5 μm into the device (equal to the thickness of the 
upper layer of polyimide). Theoretical analyses suggest that recessing the 
microelectrode will result in a reduction of overall analyte flux by a factor of           
𝜋 ⁄ (𝜋 + 4𝐿), where L is the ratio between the recession depth and microdisc radius 
[94], which in this device results in a reduction in current of just over 30% compared 
to an inlaid microdisc. The device is flexible, and was proven to be robust during 
routine laboratory use. The position of the metal layer in the neutral mechanical 
plane protects the metal interconnects and electrode sites from damage during 
bending [90]. The working electrodes are denoted W1 to W8 (Figure 3.2 a, b); the 
on-board counter electrode (Figure 3.2 c) and an external reference electrode was 
used in this study. 





Fabrication of microelectrodes on flexible substrates such as polyimide follows a 
similar process to that used on silicon [47], with the addition of polyimide deposition 
and final removal from the carrier wafer (square borosilicate glass wafers were used 
in this study). The fabrication steps are here described in chronological order, as 
follows. 
 
Figure 3.3: Schematic cross sectional images showing the process flow at 
significant stages. (i) Two layers of polyimide spin-coated onto glass wafer, 
(ii) Au/Ti deposited, (iii) Photoresist spin-coated then pattern defined, (iv) 
Au/Ti patterned by wet etch, (v) Polyimide spin-coated, (vi) Aluminium hard 
mask deposited, (vii) Photoresist spin-coated then pattern defined, (viii) 
Aluminium patterned by wet etch, (ix) Polyimide etched with reactive ion 
etching, (x) Aluminium hard mask removed by wet etch, (xi) edge of device 
cut by laser, (xii) Finished device lifted off glass wafer. 
The glass wafer was cleaned and treated with a chemical adhesion promoter 
((3-Aminopropyl)triethoxysilane, APTES), then a layer of polyimide (5.5 μm 
thickness, PI-2611, HD Microsystems) was spin-coated onto the wafer (3000 rpm, 
30 s), dried on a hot plate (200 °C, 10 min) and cured in a nitrogen oven (RT to 
200 °C at 4 °C min-1; 20 min at 200 °C; ramp to 350 °C at 2.5 °C min-1; 60 min at 
350 °C). The polyimide is processed in a liquid state, and after dehydrating and 
curing becomes solid. Photolithography (S1818 photoresist, spin coating at 
4000 rpm for 60 s, baking at 90 °C for 2 min, UV irradiance for 85 mJ cm2, 
developing for 30 s with developer MF-319/deionized water (DI H2O) at 1:1 ratio) 




was used to cover the central working area of the mask, while reactive ion etching 
(RIE) (1 min, 150 W, 150 mTorr, 15 sccm O2, 5 sccm CHF3) was used to roughen 
the exposed perimeter area of the polyimide before removal of the photoresist 
(1 min in acetone, 1 min in acetone/isopropyl alcohol at 1:1 ratio, 1 min in DI H2O). A 
second layer of polyimide was spin-coated (same parameters as before). The 
second layer of polyimide adhered strongly to the roughened perimeter area of the 
first layer of polyimide, but not strongly to the smooth central area. This ensured 
easier release of the devices (restricted to the central design area) after fabrication, 
while avoiding delamination of the second polyimide layer during processing. 
RIE (same parameters as before) was used to roughen the second polyimide layer 
and promote adhesion before an adhesion layer of Ti was sputtered (40 nm), 
followed by a layer of Au (60 nm). The metal layer was patterned with 
photolithography (S1818 photoresist, same parameters as before) and wet etching 
(Au: solution of 1 g I2, 4 g KI, and 73 mL H2O for 2 min; Ti: H2O2 ->15’’ (@50°C) + 
10’’ (@RT) + 1’ DI H2O). A third layer of polyimide (5.5 μm, same parameters as 
before) was spin-coated to cover the gold pattern. A sputtered thin film of Al (200 nm 
thickness) with adhesion layer (TiW) patterned by photolithography (S1818 
photoresist, same parameters as before) and wet etching (Al: Solution 
CH3COOH:H3PO4:HNO3:DI at ratio (4(>90%):4(>89%):1(>65%):1(100%)) for 
10 min; TiW: H2O2 ->15’’ (@50°C) + 10’’ (@RT) + 1’ DI H2O) functioned as a hard 
mask to define via holes in the top PI layer to expose the Au at the electrodes and 
the contact pads using RIE (55 min, 40 W, 150 mTorr, 15 sccm O2, 5 sccm CHF3). 
Al and TiW etchants removed the hard mask from the surface. The devices were 
then cut using a picosecond laser (355 nm, 12 ps, 50 kHz, 320 mW) to ablate the 
two layers of polyimide, with five passes at 20 mm s-1, and delaminated from the 
wafer with tweezers. 





Figure 3.4: Platinum and gold metallization. (a) Photo micrograph of platinum 
metallization, showing significant damage at the exposed sites (a section of 
contact pad is shown in this image). No cracking damage is observed at the 
edges, where the stress shielding effect of the polyimide layers protects the 
platinum. (b) Photo micrograph of gold metallization, showing no damage at 
the contact pad. 
An alternative design was trialled with platinum metallization instead of gold. Lift-off 
was used to pattern the platinum instead of wet etching, but roughness was 
observed at the edges of the platinum features (Figure 3.4 a). In addition, the 
platinum (a harder metal than gold) was significantly damaged at the larger exposed 
regions such as the contact pads and the counter electrodes, due to its stiffness 
relative to the substrate. (The platinum was undamaged in regions where the top 
layer of polyimide was present, due to the stress shielding effect of the polymer 
layers.) It was therefore determined that gold, which showed no evidence of damage 
after bending (Figure 3.4 b), was a better choice of metallization.  
3.3 Electrochemical Characterisation 
Ferrocenemethanol (Aldrich, 97% purity) was prepared at various concentrations in 
0.1 M potassium chloride (Aldrich, 99% purity) with deionised water. Electrochemical 
experiments were carried out in a Faraday cage with a μAutolab potentiostat, using 
the on-device gold counter electrode and an external Ag/AgCl counter electrode 
(BASi, USA). Control and data acquisition were performed using General Purpose 
Electrochemical System (GPES, version 4.9). 





Figure 3.5: Results of cyclic voltammetry performed separately on working 
electrodes (W1, W3, W6 and W8 only shown in this figure) in 
ferrocenemethanol (FcMeOH, 0.5 mM) at a scan rate of 0.1 V s-1. 
The microdisc electrodes were characterised using a series of standard 
electrochemical methods. Cyclic voltammetry was performed in ferrocenemethanol 
(FcMeOH), a typical redox reporter, by sweeping the voltage between the working 
electrode and reference electrode from 0 V – 0.5 V – 0 V at a rate of 0.1 V s-1, and 
measuring the current between the working and counter electrodes. The resulting 
cyclic voltammogram showed characteristic microelectrode responses, and little 
intra-device variation was observed between the working electrodes (Figure 3.5). 
Experimental results were analysed using the Saito equation [95], which describes 
the limiting current, iL, of a microdisc electrode in steady-state conditions, modified 
to account for the reduction in current due to recession into the substrate: 
𝑖𝐿  =  (4𝑛𝐹𝐷𝑐0𝑟) (
𝜋
𝜋+4𝐿
)       (3.1) 
where n is the number of electrons transferred in the reaction, F is the Faraday 
constant, D is the diffusion coefficient of the redox species (ferrocenemethanol), c0 is 
the concentration, L is the ratio of recession depth to microdisc radius, and r is the 
radius of the microdisc. Values of D = 5 × 10-10 m2 s-1 [47] and c0 = 0.5 mol m-3 were 
used. A mean limiting current of 1.76 nA was found, while the theoretical model 
predicts a limiting current of 0.99 nA; i.e. an elevated current was drawn relative to 
theoretical expectations. This could be due to the increased resistance, capacitance 
and inductance of the meandering connection, and may suggest some degree of 
surface roughness, a feature which has been found to increase the limiting current 
of a microdisc electrode [96]. A roughness factor may be estimated based on the 




effective area obtained by integrating the reduction peak of an H2SO4 cleaning 
cycle, and using the reported relation between charge and area (390 μC m-2) [97]. In 
this way, a mean roughness factor of 4.2 was obtained across the electrodes (the 
ratio of the effective to geometric area). 
 
Figure 3.6: Scanning electron micrograph of a microdisc electrode. 
Surface roughness of exposed gold areas was investigated during an earlier stage 
of work using the same fabrication method ([19], supplementary materials) and a 
root-mean-square roughness of 1.75 nm was measured using this reactive ion etch 
power of 40 W. Scanning electron micrographs also confirmed that the gold surface 
of the microelectrodes exhibited a degree of surface roughness (Figure 3.6). The 
increased current caused by this roughness during certain operations can be 
desirable, as it results in a more efficient use of the electrode area. However, the 
electrode performance is accordingly less well characterised, and does not agree 
well with the standard model for flat microdisc electrodes, although this was not a 
problem within the scope of this work. 





Figure 3.7: Current response of a microdisc electrode to a range of 
concentrations of FcMeOH; error bars are included. 
Cyclic voltammetry was used to measure how the current responds across a range 
of concentration of FcMeOH, from 10 to 500 μM, and a ‘blank’ measurement of KCl 
(0.1 M). A linear current response was observed over the entire range of 
measurement (Figure 3.7), with R2 > 0.999, indicating a very high confidence in the 
linear fit. Triplicate measurements were taken at each concentration and these were 
used to establish a limit of detection (LOD) following the IUPAC convention [98]: 
𝑥𝐿 =  ?̅?𝑏𝑙 + 𝑘𝑠𝑏𝑙        (3.2) 
where xL is the smallest current that can be reliably detected, ?̅?𝑏𝑙  and sbl are the 
mean and standard deviation respectively of the blank (KCl) measurement, and k is 
a numerical factor (a value of k = 3 was used to ensure a confidence level of 
> 99%). The LOD is obtained by substituting x = xL into the calibration function 
(Figure 3.7), giving the lowest concentration that can be detected at our chosen 
confidence level. Using this method a LOD of 0.016 mM was obtained. This result is 
comparable to that reported by Freeman et al. [46], in which a 100 μm diameter 
platinum disc electrode was found to have a LOD of 0.097 mM in ferrocene 
carboxylic acid, a similar redox reporter. Using an area ratio as a rough guide, it may 
be concluded that the 30 μm diameter microdisc electrodes have a LOD of the 
expected order of magnitude. Recessing the electrode into the polyimide substrate 
to a depth of 5.5 μm, which has the effect of reducing analyte flux by around 30%, 
may result in an elevated LOD compared to a non-recessed microdisc electrode. 




3.4 Spatiotemporal Electrochemical Sensing 
Various methods were explored during development of an appropriate 
spatiotemporal electrochemical method. Due to the potential impact on the size of 
the final ESCL design, integrating multiple counter and reference electrodes into the 
device was not considered to be satisfactory. It was also estimated that including 
multiple potentiostat units (i.e. one for each working electrode) into an embedded 
chip would increase the physical size and the power requirements to unmanageable 
levels, and set an undesirable limit on the number of working electrodes able to be 
supported by a single ESCL. Therefore, methods were considered which could be 
performed using a common counter and reference electrode, and a single 
potentiostat. 
A measurement rate approaching video-speed was also preferred, in order to 
accurately track concentration variation across the surface of the eye. First, a 
potentiostat (Autolab PGSTAT128N) with in-built multiple working electrode 
capability was used to perform measurements at each working electrode in turn at a 
high rate. However, there was a non-negligible time delay during switching (approx. 
50 ms), and significant noise was produced at the start of each measurement. 
These effects ultimately caused a relatively low measurement rate, with a poor 
signal quality. The method also used laboratory equipment of a large size with no 
clear path to miniaturisation. 
A method was therefore designed which separated the complexity of fast-switching 
electrochemical methods into two well-characterised blocks: a potentiostat running a 
single extremely simple measurement protocol, and an analogue multiplexer which 
switches automatically between a series of outputs (i.e. the working electrodes). 
Miniaturisation of simple potentiostats has been demonstrated [3], and the addition 
of an analogue multiplexer incurs little additional complexity. 





Figure 3.8: Schematic of the circuitry used for spatiotemporal experiments, 
illustrating the connections of the potentiostat (μAutolab) to the working 
electrodes (W1-8), via an analogue multiplexer driven by a microcontroller 
(Arduino Nano); to the on-device counter electrode (C); and to the external 
reference electrode (R). 
The analogue multiplexer (74HC4051 8-channel) was driven by a microcontroller 
(an Arduino Nano [99]), which addressed the electrodes one-by-one in a cyclic 
sequence (Figure 3.8). Data processing was carried out using algorithms written in 
the Python programming language. This switching was performed constantly at a 
rate of 20 Hz (20 electrodes per second) while a potentiostat (µAutolab) was used to 
conduct chronoamperometric measurement at 0.4 V for 10 s. An in-device gold 
counter electrode was used, with an external Ag/AgCl reference electrode. Due to 
the rate of switching, higher currents were drawn compared to those found in cyclic 
voltammetry (Figure 3.5, Figure 3.9), resulting from the initial formation of the 
electrical double layer at the electrode site, and from parasitic capacitance, 
inductance and resistance in the device and the circuit beyond. Experiments were 
first carried out in a beaker. Calibration in KCl (0.1 M) and FcMeOH (0.5 mM) was 
performed, and subsequently an experiment was conducted in which FcMeOH was 
added by two separate injections of 1 mL volume each, using a micropipette, to a 
beaker of KCl (initial volume ~ 5 mL), while high-speed chronoamperometric 
measurements were taken as described above. Next, an on-droplet experiment was 
conducted to mimic a sensing environment analogous to that of a tear film under a 
SCL: the device was placed on top of a droplet of either KCl or FcMeOH solution to 
form a film of liquid between the active surface of the device and the glass 
underneath. After calibration, measurements were taken while FcMeOH was 




injected into an initial KCl droplet of volume < 1 mL. Again, FcMeOH was added by 
two injections of 1 mL volume, with the micropipette placed at the W7-8 (working 
electrodes 7-8) end of the device. 
 
Figure 3.9: Raw data generated during fast-switching chronoamperometry. 
(a) Current measured over a 10 s experiment in a beaker of FcMeOH (0.5 
mM) with the potentiostat running a chronoamperometric program, and 
multiplexer performing cyclic switching through the eight working electrodes. 
(b) Detail highlighted in (a), showing a complete cycle of the eight electrodes 
(denoted W1, W2 etc). (c) Detail highlighted in (b), showing a single electrode 
response. 




Chronoamperometric data were collected in a single data stream with no sub-
categorization of the individual response of each working electrode; the raw signal 
effectively consisted of a repeating eight-step sequence of 50 ms 
chronoamperometric measurements (Figure 3.9). 
 
Figure 3.10: Intra-device variation in current drawn and path length. (a) 
Current measured during high-speed chronoamperometry, with the response 
of each working electrode illustrated (duplicated from Figure 3.9 b); (b) 
Electrical path length of each working electrode as measured from electrode 
to connection pad in-device. (Point-to-point path length is illustrated here; the 
true path length following the meanders would be a multiple of each of these 
values). 
In electrochemical characterisation using cyclic voltammetry, at a sweep rate of 
0.1 V s-1, the current responses of the electrodes were found to be very similar 
(Figure 3.5). However, in high-speed chronoamperometric measurements (where 
the voltage step occurs at a rate greater than 400 V s-1), a range of current 
responses was observed among electrodes (Figure 3.10 a). In high-speed 




measurements, the effects of parasitic capacitance, inductance and resistance are 
of far greater importance. The current derived from the electrochemical response is 
combined with contributions from these additional effects. In this study, the variation 
in current response among the working electrodes was found to follow the variation 
in path length of meandering connections within the device (Figure 3.10 b; path 
length of in-device connections is variable, see Figure 3.1 a). It follows that part of 
the variation in current drawn during high-speed measurement derives from the 
variation in length of electrical connections in the device. Wire connections in the 
subsequent circuitry were also not always equal between electrodes; therefore it is 
likely that similar effects contributed beyond the device as well as within. 
Electrical path length is greatly increased using meandering connections rather than 
straight wires. In a small device, proximity of connection paths is also usually 
increased with meanders. Although in this study the effect of parasitic capacitance, 
induction and resistance was easily corrected for during calibration, it is worth noting 
this result of using meandering connections and potentially limiting their use when 
not necessary, e.g. for wires in the circumferential direction of a smart contact lens 
[19]. 
An algorithm was designed to detect and separate the signals from the eight 
individual working electrodes (W1-8). Mean current was obtained from the 25 ms to 
45 ms segment of each 50 ms sub-measurement. This period was chosen to avoid 
the initial non-Faradaic signal and any switching noise at either end of the 
measurement period. This process generated a single data point from each sub-
measurement, each labelled to one of the eight working electrodes. Linear 
interpolation was used to smooth the data between pairs of consecutive time points 
and to avoid a rolling refresh effect, since the data at each electrode is updated only 
once in every eight samples. 





Figure 3.11: Signal processing during spatiotemporal electrochemistry and 
the results of two experiments. (a) Detail of the signal from W1 during on-
droplet measurements of ‘high’ (FcMeOH 0.5 mM), ‘zero’ (KCl 0.1 M) and 
variable (‘KCl + FcMeOH’, where FcMeOH was injected into a KCl droplet at 
the W7-8 end of the device) concentrations. Annotations illustrate the 
calibration method. (b) FcMeOH concentration at all electrodes throughout 
the 10 second beaker experiment. Injections of FcMeOH are illustrated. (c) 
FcMeOH concentration at all electrodes throughout the 10 second on-droplet 
experiment. Injections of FcMeOH are illustrated. (Note: a single anomalous 
data point has been removed in W1) 
Calibration between an average ‘high’ value (FcMeOH, 0.5 mM) and ‘zero’ value 
(KCl, 0.1 M) was performed individually for each working electrode. Figure 3.11 a 




provides a detail of this process during the droplet experiment, showing three 
measurements (only W1 shown for clarity): the W1 ‘high’ (indicated with a solid 
horizontal line), W1 ‘zero’ (indicated with a dotted horizontal line) and the signal 
generated by W1 during time-varying concentration (‘KCl + FcMeOH’, marked with 
crosses). Figures 2.11 b and c show the time-varying concentration at each working 
electrode over the 10 second measurement period for the beaker experiment and 
the on-droplet experiment. In the beaker experiment there was virtually no spatial 
inhomogeneity of concentration across the device, and thus the eight working 
electrodes recorded almost identical concentrations at all times. The effects of the 
two injections of FcMeOH can be clearly observed in the data; the concentration 
rises slowly as the FcMeOH mixes with the KCl solution. 
In the on-droplet experiment, the measured concentration rose very quickly upon the 
first injection. This was likely due to bulk flow of FcMeOH pushing the initial KCl film 
away. Diffusive and turbulent mixing would have taken place at the interface of the 
two fluids, but in the laminar flow regime it is likely that the incoming fluid simply 
pushed away the majority of the initial fluid with only a minor amount of mixing. 
Thus, the measured concentration rose to nearly 0.5 mM after the first injection (I1). 
The effect of the second injection (I2) was not so pronounced, because the 
concentration under the electrodes was already fairly high. It is also possible to 
observe in the data at various times a difference in the concentration observed at 
each electrode (Figure 3.11 c, e.g. at the second injection, t = 8), as fluid mixing was 
less efficient in this experiment compared to the beaker experiment, resulting in a 
not-always-homogeneous concentration across the device. These effects are 
explored in more detail with reference to Figures 2.12 a and b, but in Figure 3.11 c it 
is already clear that W1-2 experienced a slightly lower concentration throughout the 
experiment; since FcMeOH was injected from the W7-8 end of the device, it is likely 
that the initial KCl droplet was pushed in the direction of W1-2, resulting in this lower 
concentration. Figure 3.12 c also shows that the W1-2 end of the device was 
situated closer to the glass at the start of this experiment, such that the KCl situated 
there would have moved and mixed less readily than the rest of the droplet. 





Figure 3.12: Visualisation of a spatiotemporal electrochemical measurement. 
(a) Illustration of the droplet experiment in schematic cross-section. FcMeOH 
is injected into a droplet of KCl from the W8 end of the microelectrode device 
(reference electrode not shown). (b) Still “frames” from the colour map “video” 
of concentration across the device. Time points are chosen to illustrate 
various features of the flow, particularly at I1 (t ≈ 2.5) and I2 (t ≈ 8). See Video 
3.1 (Supplementary Materials) for full video. (c) Photograph of experimental 
setup, showing the microelectrode device resting on a KCl droplet (reference 
electrode not shown). 
In order to better visualise the concentration flow the data were rescaled between 0 
and 1, which was then used to prepare a colour map representing concentration at 
each electrode site (Figure 3.12 b). This can be viewed in real time (Supplementary 
Materials), while Figure 3.12 b shows some representative frames from the video. It 
is possible to see in these frames the initial injection of FcMeOH (from the W7-8 end 
of the device, e.g. t = 2.59 to 2.84) followed by mixing and homogenisation after I1 
(e.g. t = 3.14). The effects of I2 can be seen in the same way (e.g. t = 8.39, where a 
larger volume underneath W3-8 perhaps allowed circular mixing which was 
observed at W3-4 before W5-6) and the unmixed solution at W1-2 (e.g. t = 9.54). 
When viewed in its entirety, the electrochemical video provides a clearer 




visualisation of the flow of analyte across the device, with both bulk flow and 
diffusive mixing visible. 
3.5 Conclusion 
A linear 8 x 1 array of individually addressable microelectrodes was designed and 
fabricated on a flexible polyimide substrate. The device was flexible and robust to 
mechanical deformation when gold metallization was used, with no observed 
damage after manual deformation or standard laboratory use, while platinum 
metallization was observed to undergo damage after bending of the device. 
Standard electrochemical characterisation procedures produced expected 
microelectrode-like behaviour, while both circuit effects and increased surface 
roughness of the gold working electrodes was found to lead to a larger than 
expected current drawn during cyclic voltammetry. A spatiotemporal electrochemical 
method was described and demonstrated using the microelectrode device, and 
examples of spatiotemporal concentration variation in a beaker and a droplet 
experiment were illustrated. 
The findings from this study were used to inform the next stage of device design. 
The useful section of the signal produced during fast-switching chronoamperometry 
was much smaller than the total current drawn from each working electrode, which 
also varied significantly from electrode to electrode. Meandering connections 
contributed to this issue due to their increased parasitic capacitance, inductance and 
resistance during high-speed electrochemical measurements when compared to 
straight wires. In an ESCL, meandering connections may be avoided by designing 
wires to travel only in the circumferential direction, and avoiding radial travel (since 
previous studies have shown that connections in the radial direction must be of a 
pre-defined serpentine form to avoid buckling behaviour in the substrate after 
thermoforming). The useful section of the signal could be also increased, and 
therefore signal to noise ratio decreased, by using connected arrays of microdisc 
electrodes instead of individual microelectrodes. 
No significant flaws were encountered with this design or fabrication method, and it 
was concluded that the polyimide core of the polyimide/TPU SCL platform is a 
suitable substrate for microelectrode arrays built for SCL integration. 
  




4 Flexible Through-Flow Ultramicro and Nanoband 
Electrodes 
 
Miniaturisation of the working electrode in an electrochemical system improves 
sensing performance. However, reducing feature size in the image plane of 
photolithographically-defined structures incurs increasing cost in terms of design, 
tooling, process complexity and materials. Nanoelectrodes – electrodes with at least 
one relevant dimension smaller than 100 nm – can be fabricated more easily in a 
nanoband architecture, using the thickness of deposited metal layers to define the 
nano-dimension of the electrode, since very thin films of metal can easily be 
deposited in a standard cleanroom. 
Nanoband electrodes have not been widely reported on flexible substrates, but there 
is no fundamental reason that the silicon-based process could not be adapted to a 
flexible substrate. However, in this chapter a further-simplified fabrication process is 
presented which avoids the need for conventional photolithography and instead 
combines thin-film technology with laser excision to produce flexible nanoband 
electrodes capable of being produced on a roll-to-roll basis. The same core 
polyimide technology found in the polyimide/TPU SCL platform is used, with a view 
to possible integration of these nanoband electrodes into an ESCL. 





Figure 4.1: Overview of the through-flow electrode device. (a) Photograph of 
a nanoband mesh electrode device, with a schematic cross-section showing 
part of the fabrication method. (b) Visualisation of the through-flow geometry 
of the electrodes during on-skin sweat sensing. 
The fabrication process produces a connected array of nanoband electrodes of 
arbitrary planar form, with the unusual property of a through-flow architecture 
(Figure 4.1). The sensing medium is free to flow past the nanobands, which (for 
certain scenarios such as flow environments like the tear film, or on-skin 
measurement) can engender a more efficient sensing environment. In this chapter 
the design and fabrication of these devices, characterisation of the physical form of 
the electrode sites, the electrochemical sensing properties, and the resilience to 
mechanical deformation and damage are demonstrated and discussed. A through-
flow experiment, in which the device acts as an active-sensing filter through which a 
flow of fluid of varying concentration passes, is also illustrated. Finally, possible 
integration into an ESCL platform is discussed. 
 





The nanoelectrode devices comprise a layer stack of polyimide (5.5 µm), gold 
metallization (60 nm) with a titanium adhesion layer (40 nm), and a second layer of 
polyimide (5.5 µm). The total thickness of the stack is 11 μm. Due to the planar 
nature of the layer stack, all electrode sites shared an electrical connection via the 
gold metallization. After construction of the layer stack, electrode sites were digitally 
defined using laser excision. The laser could operate in two modes: localised pulse, 
or a continuous line. In this study two different devices were designed to investigate 
the electrochemical properties of the two main electrode geometries which could be 
created in these two modes: macropore (Figure 4.2) and micropore (Figure 4.3). 
Devices with features created by continuous line excision would be generally 
analogous to the macropore electrodes, while the micropore electrodes were 
created by localised laser pulses and represent the minimum feature size producible 
with this laser. The macropore electrodes consisted of a 4 x 20 array of circular 
holes (diameter = 455 μm), visible to the naked eye. The micropores consisted of 
either a 20 x 100 array of teardrop-shaped holes (diameter ≈ 22 μm) with 200 μm 
spacing, or a 16 x 100 array with 160 μm spacing.  
 
Figure 4.2: The macropore device. (a) Digital design schematic. (b) Photo 
micrograph of a macropore electrode. (c) Scanning electron micrograph of 
the side-view of the corner of the device, showing the layer stack, gold 
nanoband and edge profile. 
The macropore electrodes were designed such that the predominant form of the 
diffusion field would be cylindrical. The radius of curvature of the macropore shape 
(228 µm) is much greater than the thickness of the nanoband (60 nm), and hence 
the diffusion field may be approximated as that of a linear nanoband. Scanning 
electron microscopy of the sidewall after continuous laser excision shows the gold 




nanoband in the centre of the two polyimide layers (Figure 4.2 c). For any planar 
design with radius of curvature much larger than the nanoband thickness a linear 
nanoband approximation is valid. 
 
Figure 4.3: The micropore device. (a) Digital design schematics for both 
sparse and dense array types. (b) Photo micrograph of the micropores. (c) 
photo micrograph at higher magnification, showing the gold band in the 
middle of the stack. 
Micropore devices were created with both dense and sparse array types (Figure 
4.3 a). The denser array (160 µm spacing) was used for imaging to increase feature 
representation, but all electrochemical tests were carried out with the sparser array 
(200 µm) to minimize diffusion field overlap. 
 
Figure 4.4: Scanning electron micrographs of the micropore electrodes at 45° 
(a, b) and top-down (c). An electron-depleted region is visible around the 
ablation site, and a filigree-like pattern of gold is seen in the wider part of the 
pore. 
The physical form of the macro and micropores was characterised using a 
combination of optical microscopy and scanning electron microscopy. The electrode 
sites in the macropores were defined by the sidewall profile produced during laser 
ablation, while the micropore electrodes derived both their sidewall angle and their 
shape from the beam characteristics. The micropores exhibit minimal variation from 




pore to pore and across different devices (Figure 4.3 b, Figure 4.4 a). The laser 
produced teardrop shaped holes with an average sidewall angle of 52° to horizontal 
(Figure 4.4 b, c), though the angle is shallower at the top and becomes steeper after 
the Au/Ti layer (Figure 4.5). Thus, the pore area at the top was larger than at the 
bottom (762 μm2 and 235 μm2 respectively).  
 
Figure 4.5: Schematic of the micropore sidewall profile. The laser produces 
holes that are wider at the top of the substrate than the bottom. 
The micropores all contained a filigree-like pattern of gold at the wider part of the 
teardrop; this was consistently of the order of 1-2 μm in size, and was remarkably 
similar in every micropore (Figure 4.4 c). It is hypothesised that this derived from the 
effect of heat dissipation in the gold during laser ablation: the widest part of the 
ablation site receives the least laser intensity and excess heat dissipates into the 
surrounding metal, such that this filigree pattern represents to some extent the 
channels of energy flow during the ablation process. Experiments with a less 
powerful laser produced holes with larger filigree patterns, which provides some 
support for this hypothesis. Due to this feature, it is more appropriate to class the 
micropore electrodes as ultramicroelectrodes rather than nanoelectrodes. 
Visible in the scanning electron micrographs, but not in the optical microscope 
images, is a dark region surrounding each micropore. It is hypothesised that the 
laser partially oxidised the polyimide in the blast region, resulting in fewer electrons 
available for detection during scanning electron microscopy (which operates by 
detecting secondary electron emission). This effect may have subtle consequences 
regarding electrochemical performance, particularly in the speed at which double-
layer capacitance is formed at the electrode sites during measurement, though 
investigation of this effect is outwith the scope of this thesis. 






Figure 4.6: Sequence of schematic cross-sections illustrating fabrication 
steps for the nanoband mesh electrodes. (a) Two layers of polyimide spin-
coated onto a glass wafer. (b) Au/Ti sputtered onto the polyimide. (c) A 
second layer of polyimide spin-coated over the metal layer. (d) Laser ablation 
defines electrode sites and device shape. (e) Device is released from glass 
wafer. (f) A physical mask defines contact pad areas. (g) Reactive ion etching 
removes top layer of polyimide to expose gold contact site. 
The glass wafer was cleaned and treated with a chemical adhesion promoter ((3-
Aminopropyl)triethoxysilane, APTES), then a layer of polyimide (5.5 μm thickness, 
PI-2611, HD Microsystems) was spin-coated onto the wafer (3000 rpm, 30 s), dried 
on a hot plate (200 °C, 10 min) and cured in a nitrogen oven (RT to 200 °C at 
4 °C min-1; 20 min at 200 °C; ramp to 350 °C at 2.5 °C min-1; 60 min at 350 °C). 
Photolithography (S1818 photoresist, spin coating at 4000 rpm for 60 s, baking at 
90 °C for 2 min, UV irradiance for 85 mJ cm2, developing for 30 s with developer 
MF-319/deionized water (DI H2O) at 1:1 ratio) was used to cover the central working 
area of the mask, while reactive ion etching (RIE) (1 min, 150 W, 150 mTorr, 
15 sccm O2, 5 sccm CHF3) was used to roughen the exposed perimeter area of the 
polyimide before removal of the photoresist (1 min in acetone, 1 min in 
acetone/isopropyl alcohol at 1:1 ratio, 1 min in DI H2O). A second layer of polyimide 
was spin-coated (same parameters as before). The second layer of polyimide 
adhered strongly to the roughened perimeter area of the first layer of polyimide, but 




not strongly to the smooth central area. This ensured easier release of the devices 
(restricted to the central design area) after fabrication, while avoiding delamination 
of the second polyimide layer during processing. 
An adhesion layer of Ti was sputtered (40 nm) followed by a layer of Au (60 nm). A 
second layer of polyimide was spin-coated using identical settings to the previous 
two. A picosecond laser (355 nm, 12 ps, 50 kHz, 320 mW) was used to ablate the 
two layers of polyimide and the gold, using five passes at 20 mm s-1, in order to 
define the outlines of the devices and to etch the pores. For the smaller pores, a 
localised pulse was used to create the smallest possible opening, while the larger 
pores were defined by a circular path and the edges by straight paths. The devices 
were delaminated from the wafer using tweezers. To etch contact pads, a physical 
mask (e.g. a glass slide) was used to cover most of the device, with only the desired 
contact region left exposed. The top layer of polyimide was ablated using reactive 
ion etching (60 mTorr, 15 sccm O2, 5 sccm CHF3, 80 W). 
An alternative method to create electrical contact without reactive ion etching would 
be to pierce the device with multiple small pins (i.e. a crocodile clip with very sharp 
teeth). This could eliminate the need for the final step in the fabrication process 
described above. 
4.3 Electrochemical Characterisation 
For electrochemical measurements, ferrocenemethanol (Aldrich, 97% purity) was 
prepared at various concentrations in 0.1M potassium chloride (Aldrich, 99% purity) 
with deionised water. Electrochemical experiments were carried out in a faraday 
cage where possible, using a μAutolab potentiostat, with a platinum counter 
electrode and an Ag/AgCl reference electrode (BASi, USA), in static solution unless 
stated otherwise. Control and data acquisition was performed using General 
Purpose Electrochemical System (GPES, version 4.9). 
4.3.1 Theoretical Model 
In steady-state conditions, the limiting current of a microdisc electrode is described 
by the Saito equation [95]: 
𝑖𝑙  =  4𝑛𝐹𝐷𝑐0𝑟         (4.1) 
where n is the number of electrons transferred in the reaction, F is the Faraday 
constant, D is the diffusion coefficient of the redox species (ferrocenemethanol), c0 is 




the concentration, r is the radius of the microdisc, and il is the limiting current. From 
triplicate measurements at a concentration of 0.5 mM and a sweep rate of 0.1 V s-1, 
a limiting current of il = 1.56 μA was calculated. In order to isolate the behaviour of 
the micropores a separate test was performed in which the edges of the device were 
covered with epoxy (since the edges of the device acts as a linear nanoband). It was 
found that 51% of the current derives from the micropores, which yields a value of 
il,micropores = 0.80 μA. This number was used in the following analysis, and values of 
D = 5×10-10 m2 s-1 [47] and c0 = 0.5 mol m-3 were used.  
It was assumed that the analyte flux from each side of the substrate was equivalent 
in this theoretical model to a separate electrode site. Recession of the electrode in a 
microdisc (and circular nanoband) has been calculated to reduce analyte flux by a 
factor of 𝜋/(𝜋 + 4𝐿) where L is the ratio between the recession depth and microdisc 
radius [94], and this analysis considers the smallest radius in the analyte diffusion 
field from each sides of the substrate, i.e. a minimum radius of rabove = 11 µm from 
above and rbelow = 8 µm from below, while the recession depth is 5.5 µm in both 
cases (Figure 5). As the electrode spacing is much greater than the electrode size, 
largely independent diffusion fields can be assumed; thus total current is defined as: 
𝑖𝑙 = 2000 × 𝑖𝑙,𝑠𝑖𝑛𝑔𝑙𝑒  ,        (4.2) 
where il,single accounts for diffusion from both above and below. Finally, a standard 
recessed nanoband electrode yields approximately half the current of a microdisc of 











and a theoretical limiting current of il,theory = 1.1 µA. This value is within the same 
order of magnitude as (and slightly higher than) the observed limiting current of 
0.8 µA. Reduction in current versus the theoretical model may result from (i) 
accidental coverage of micropore sites while covering the edges of the electrode in 
epoxy, and (ii) some tolerance due to the approximations made regarding physical 
pore structure (since the models assume straight-wall recessed architecture), as 
well as other deviations from the ideal model such as polymer substrates, sidewall 
inhomogeneity and more. However, this result is a good indication that the 
micropores act akin to recessed nanoband electrodes with two-fold diffusion 
characteristics from the through-flow architecture. 
(4.3) 




Linear nanobands along the sidewall of an exposed edge do not have a well 
described theoretical limiting current in the literature, but the cyclic voltammetric 
measurements indicate approximately 4× current increase per unit area using linear 
nanobands when compared to micropores. This may be attributed to the open 
nature of the sites, and the fact that the diffusion field can wrap all the way around 
the thin substrate. 
4.3.2 Electrochemical Testing 
Nanoelectrodes excel in two primary characteristics: low limit of detection, and the 
ability to perform measurements at a much faster rate than macroelectrodes [44]. 
These features were investigated with a benchmark comparison to similar nanoband 
sensors fabricated on silicon [45]. The effect of sweep rate on the diffusion and 
mass transport characteristics of the electrodes was also investigated. 
Cyclic voltammetry was used to investigate how the current responds to various 
concentrations of FcMeOH, ranging from 0.5 to 500 μM. Triplicate ‘blank’ 
measurements of 0.1 M KCl were performed, and these were used to establish a 
limit of detection (LOD) following the IUPAC convention [98]: 
𝑥𝐿 =  ?̅?𝑏𝑙 + 𝑘𝑠𝑏𝑙        (4.4) 
where xL is the smallest current that can be detected, ?̅?𝑏𝑙 and sbl are the mean and 
standard deviation respectively of the blank (KCl) measurement, and k is a 
numerical factor (a value of k = 3 was used to ensure a confidence level of > 99%). 
The LOD is obtained by substituting x = xL into the calibration function of the device 
(Figure 4.7), giving the lowest concentration that can be detected at our chosen 
confidence level. Using this method, a LOD was be determined for each device 
(Table 4.1). 
 
Table 4.1: Limit of detection of a nanoband device, a macroelectrode 
of equivalent area, and the nanoband mesh devices. 
Device Limit of detection [μM] 
Macroelectrode (Platinum Disc) [46] 97 
Nanoband array [46] 0.10 
Macropore mesh device 0.12 
Micropore mesh device 0.67 
 




In previous literature a silicon-based recessed nanoband array achieved an LOD of 
1.0 × 10-7 M with ferrocene carboxylic acid, a similar redox reporter [46]. The 
authors also calculated the LOD of a macroelectrode of equivalent area (Table 4.1). 
This nanoband array had a total electrode area of 1.1 × 10-8 m2; using a value of 
60 nm nanoband width, a macropore device electrode area of 1.0 × 10-8 m2 is 
calculated, and a micropore device electrode area (including edges) of 1.1 × 10-8 m2. 
It is therefore asserted that the silicon-based nanoband array is a good benchmark 
against which to compare the devices in this study, due to the electrode area and 
the similar geometry of the electrode sites. 
 
Figure 4.7: Current response to a range of concentrations for the macropore 
and micropore devices. 
Both the macropore and micropore devices exhibited a highly linear current 
response to change of concentration, with R2 values > 0.999 for the linear fit (Figure 
4.7). We calculated a LOD of 6.7 × 10-7 M for the micropore device, and 1.2 × 10-7 M 
for the macropore device (Table 4.1). 
These results indicate that the sensors exhibit sensitivity on the same order of 
magnitude as other state-of-the-art nanoband devices, without requiring expensive 
photolithographic techniques. It is interesting to note that the macropore device 
performed a little better than the micropore; the gold filigree-like structures found in 
the micropores were not observed in the linear nanoband areas (i.e. the macropores 
and the device edges), and it is therefore hypothesised that these regions display 
more nanoband-like behaviour than the micropores. Since the linear nanoband 
structures also exhibited a higher current drawn per unit area when compared to the 
micropores, it may be concluded that features made using the laser operating in a 




continuous mode have better sensing characteristics than those made using 
localised pulses, although the small pores formed during the latter method may 
bring other benefits, such as flow-speed control and physical filtering of sensing 
media. 
Chronoamperometry and cyclic voltammetry were both performed at the rate limit of 
the µAutolab potentiostat to determine how quickly a reliable measurement may be 
taken. Cyclic voltammery was performed at a sweep rate of 3 Vs-1, which, with 
voltage steps of 1.06 mV, gave a sampling time of 350 μs. Chronoamperometry was 
performed with a sampling time of 50 μs. 
Cyclic voltammograms were taken in triplicate using a macropore device. Very low 
deviation was seen between measurements and no anomalies were observed, 
demonstrating that the devices performed well at this rate (Figure 4.8 a). In the 
slightly faster case of chronoamperometry, triplicate measurements were taken and 
error plotted for each time point (Figure 4.8 b). The consistently low error observed 
here leads to the conclusion that the devices perform well at the operational limit of 
our potentiostat, giving a working sample rate of at least 20 kHz. 
 





Figure 4.8: Cyclic voltammetric and chronoamperometric investigations into 
response speed. (a) Cyclic voltammetry at a sweep rate of 3 Vs-1, performed 
in triplicate and demonstrating no errors or anomalies between the three 
measurements. (b) Chronoamperometric measurements performed in 
triplicate, demonstrating low measurement error at all time points. 
Cyclic voltammetry shows a near-sigmoidal response at a sweep rate of 
ν = 0.1 V s-1 (Figure 4.9), which is characteristic of a nanoelectrode array in steady-
state conditions [45]. There is some current from parasitic capacitance, which arises 
through non-Faradaic charging of the capacitance between the gold layer and the 
solution through the polyimide substrate [45]; this additional current may be 
observed in the difference between the forward and backward sweeps, and it is 
possible to correct for it either with a blank (KCl only) measurement, or more 
approximately by averaging the forward and backward sweeps. The capacitive 
current is proportional in magnitude to sweep rate ν (which is clearly demonstrated 
in Figure 4.9) and is insensitive to potential. 





Figure 4.9: Cyclic voltammetry of FcMeOH in 0.1 M KCl, at sweep rates of 
25, 50, 75, 100, 200, 500 and 1000 mV s-1: (a) Micropore device at 0.5 mM 
FcMeOH, (b) Micropore device at 0.1 mM FcMeOH, (c) Macropore device at 
0.5 mM FcMeOH, (d) Macropore device at 0.1 mM FcMeOH. 




At very slow sweep rates the diffusion field of each electrode site grows to the point 
where they begin to overlap. The closer the features (micropores, macropores or 
linear nanobands), the higher the sweep rate at which this overlap will occur. This 
results in a decrease in area efficiency over time, as the diffusion fields eventually 
combine and mass transport approaches the macroelectrode case. 
4.3.3 Electrochemical Performance after Mechanical Testing 
 
Figure 4.10: Current response to 0.5 mM FcMeOH after progressive stages 
of damage: (1) the original state, (2) multiple permanent folds, (3) permanent 
crumpling and scratching, (4) three small cuts added, (5) a large cut added 
which bisects the sensing area, and removal of a small piece of the device. 
Cyclic voltammetry was performed at various stages of mechanical deformation and 
damage to investigate the effect on sensing performance of the nanoband mesh 
electrodes (Figure 4.10). Although non-Faradaic charging current increased as more 
folds and cuts were introduced, when this was compensated for (by averaging the 
current during the forward and backward voltage sweeps) very little change was 
observed as damage progressed. Thus, while the nanoband mesh devices are 
extremely thin compared to silicon- or even polymer-based electrode devices [100–
102], with overall thickness of 11 μm and a gold layer thickness of only 60 nm, they 
appear to be remarkably robust to mechanical deformation, likely due to the strength 
of the polyimide layers and the fact that the metal layer resides in the neutral 
mechanical plane. During bending the polyimide layers experience tensile or 




compressive forces, while the gold layer experiences (virtually) no such force. This 
design protects the integrity of the metal layer, and allows the sensor to continue 
functioning unaltered under severe mechanical stress or deformation, as 
demonstrated in Figure 4.10 (1-3). Additionally, the electrode sites are largely 
protected from physical damage such as scratching by their position in the sidewall 
of micropores, or the edges of the device in general. In the event of a cut through 
the device, or even a piece missing, the nature of the substrate is such that there is 
significant redundancy in the sensing array and robust electrical connection is 
maintained, as demonstrated in Figure 4.10 (4-5). 
4.4 Through-Flow Experiment 
To test the devices in a flow environment, an experiment was designed in which 
fluid of varying concentration flowed through a micropore electrode array, such that 
the array acted akin to an active-sensing filter. 
 
Figure 4.11: Photograph of the experimental setup during the through-flow 
tests. Inset shows a cross-sectional photograph of the nanoband mesh 
electrode acting as a filter through which flowing liquid passes. 
A flow cell was created with two fluid inputs: KCl (0.1 M) and FcMeOH (0.5 mM). 
The two syringes were connected in a Y-junction into the main flow line (Figure 
4.11); the fluid then passed through the micropores of a nanoband mesh electrode, 
sealed into the flow line using epoxy resin (Figure 4.11 inset), which acted as the 
working electrode. A counter electrode (platinum wire mesh) and reference 
electrode (Ag/AgCl) were inserted into the flow line after the working electrode.  





Figure 4.12: Cyclic voltammograms before and after integration of the 
nanoband mesh into the flow cell. (a) Both cyclic voltammograms. (b) Re-
scaled plot of cyclic voltammogram taken after integration. 
Cyclic voltammograms taken in static fluid before and after integration of the device 
into the flow cell showed an expected decrease (slightly greater than 10×) in current 
(Figure 4.12), as only a subset of the micropores and none of the device edge were 
in contact with the sensing medium. The characteristic form of the current response 
to cyclic voltammetry was preserved after integration (Figure 4.12 b). 
Chronoamperometric measurement was performed (0.4 V for 30 s) during which 
‘high’ concentration (FcMeOH, 0.5 mM; KCl, 0.1 M) and ‘zero’ concentration 
(FcMeOH, 0 mM; KCl, 0.1 M) fluid was pumped alternately through the flow cell. 
Figure 4.13 shows three measurements taken during different pumping profiles, in 
which the blue shading indicates pumping of FcMeOH and the white indicates KCl, 
while the guidelines indicated the approximate level of ‘high’ and ‘zero’ 
concentrations. The design of the flow system results in a non-binary concentration 
measured at the working electrode; instead, evidence of mixing and flushing of the 
previous fluid is observed, with a characteristic decay trending from high 
concentration to zero (e.g. Figure 4.13 b, t = 12 s), or vice versa (e.g. Figure 4.13 a, 
t = 11 s). With established linearity in this concentration range (Figure 4.7), a simple 
calibration method should be sufficient to infer the concentration of the fluid passing 
through the nanoband mesh electrodes, although, due to the effects of flow-
mediated replenishment of analyte in the diffusion fields, the relationship between 
current measured and concentration may be flow-speed dependant. 





Figure 4.13: Current response during three 30 s chronoamperometric 
measurements in which ‘high’ and ‘zero’ concentration FcMeOH was pumped 
through the flow cell at various times. Shaded sections indicate flow of ‘high’ 
concentration FcMeOH, and approximate guides of the maximum ‘high’ 
(0.5 mM) and ‘zero’ (0 mM) concentration values are indicated by dashed 
lines. 
In addition to through-flow architectures in flow cells such as this, suitable for 
continuous monitoring of concentration profiles of analytes in (e.g.) automated 
fabrication, water purification, fluid analysis, etc, a similar architecture may be 
achieved in sweat sensing. Electrochemical sweat sensors currently face the 
challenge of fluid pooling either underneath or on top of the device, rendering the 
measurements made therein inaccurate, since the newer sweat is mixed 
indeterminately with older fluid. By combining the nanoband mesh electrodes with a 




wicking fabric on top, sweat would be drawn through the device into the fabric and 
wicked away, ensuring that only the most recent, and therefore most accurate, 
concentration levels are measured. 
4.5 Conclusions 
In this chapter, a new method of fabricating flexible nanoband electrodes has been 
introduced and discussed. Physical characterisation of the electrode sites created 
during different laser excision modes was described. The electrodes performed well 
during electrochemical characterisation, with comparison to equivalent 
macroelectrodes and equivalent silicon-based nanoband electrodes indicating 
preservation of the desired nanoelectrode sensing characteristics when adapting 
nanoband technology to this flexible substrate and simpler fabrication method. The 
devices proved extremely robust to mechanical deformation and damage, which, 
combined with the possibility of a cheap roll-to-roll production method, suggests that 
this work could lead to a viable high-quality disposable biosensor technology. A 
through-flow sensing architecture was illustrated by a flow cell experiment, in which 
a nanoband device provided continuous information on the concentration of a fluid 
flowing through the micropores. This may have applications in biosensing, for 
example in tattoo-based electrochemical sensors, in which sweat could be 
monitored as it flows through a skin-mounted device. It may also be applicable to 
production environments in which fluid flows need to be monitored for their chemical 
composition. 
Due to the need to integrate separate components such as silicon chips and an 
antenna into an ESCL, the utility of a photolithography-free fabrication method is 
made somewhat redundant. Nanoband electrodes also may be more vulnerable to 
biofouling, as the architecture of both the macropores and micropores are less well-
defined, deeper, and rougher than planar microelectrodes. It was therefore 
determined that a microelectrode technology would be a better choice for ESCL 
integration. However, the excellent sensing performance derived from using an 
array of connected nanoelectrodes in this study indicated that connected arrays of 
microelectrodes may improve the quality of electrochemical measurements taken in 
the eye when compared to the single microelectrodes designed in Chapter 3. 
  




5 Interpreting Measurements Made in the Tear Film  
 
In most cases, electrochemical measurements performed in the tear film are 
intended to be used to create estimations of the corresponding concentration of the 
analyte in the blood. However, the time-varying concentration profile of an analyte in 
the blood is not simply replicated in the tear film. The physiological processes which 
transport the analyte from the blood stream into the lachrymal fluid result in a 
complex mathematical distortion of the initial time-series profile; i.e. the time-series 
trend of concentration in the tear fluid is a distorted version of that in the blood. 
Therefore, if electrochemical measurements are taken in the tear film and assumed 
to be an accurate indication of concentration in the blood, the conclusions made 
using this data risk being catastrophically inaccurate. 
In Chapter 3 a spatiotemporal electrochemical method was discussed which would 
provide information about the flow of lachrymal fluid across the eye, therefore 
producing more accurate information about the in-flowing fluid, in order to reduce 
the measurement distortion inherent to ESCLs. However, the distortion resulting 
from the transport of analyte from the blood to the lachrymal fluid must also be 
corrected for if sufficiently accurate estimates are to be achieved. 
In this chapter a method based on a neural network is described which corrects this 
measurement distortion. Crucially, it learns a patient’s individual measurement 
distortion, and assumes very little about the nature of the underlying process, 
making it patient-specific, generic, and applicable to a wide range of analytes and 
measurement scenarios. 
5.1 Theory & Methods 
The problem of measurement distortion has been observed and well-described in 
the case of glucose measurement in the interstitial fluid (ISF) [7]. However, the 
relationship of glucose concentration in the blood to the ISF is comparatively simple 
to the case of lachrymal fluid, and can be modelled using a two-compartment model 
to a degree of accuracy which is acceptable in clinical use. Calibration to an 
individual patient is usually necessary due to variation in physiology, but after 
calibration the mathematical model sufficiently corrects for the difference between 
glucose concentration measured in the ISF and that found in the blood to make 
useful diagnostic conclusions. In contrast, measurements performed in the tear film 




face a greater challenge in correcting measurement distortion, as the analytes 
progress through a more complex metabolic pathway in reaching the tear fluid from 
the blood plasma. 
To draw accurate conclusions from non-invasive measurements such as those 
made in the tear film it is necessary to correct for the difference between the 
measured data (i.e. the measured concentration in the tear film) and the underlying 
data (i.e. the concentration in the blood), which includes (but is not limited to) the 
difference between the concentration of analyte in the sensing medium and the 
concentration in the blood (as in most cases it is blood-analyte concentration with 
which we are concerned). This challenge is made difficult by a number of factors: 
1. The metabolism of analytes, and the pathways by which they find their way 
from the blood to the sensing media, are complex and not always well-
understood. 
2. These metabolic profiles and pathways are patient-specific – it is not 
sufficient to measure the relationship between (e.g.) tear-glucose and blood-
glucose in one patient and to assume the same relationship exists in another 
patient [67,103]. 
3. The metabolic profile may be situationally dependent – e.g. cortisol secretion 
has been found to be covariate with a range of other factors, including eating 
a meal [104], while performing exercise, sleeping, or the time of day may 
alter the proportion of blood glucose which is filtered through into the tear 
film or sweat. 
An example of (2), above, is found in interstitial fluid (ISF) glucose, where a time 
constant characterizing the transfer rate of blood glucose into ISF ranges from 
τ = 7.1 min to τ = 20.5 min among different patients [7]. 
The consequence of these factors is that currently (in Q4 2019), in most cases, it is 
not possible to safely use data derived from non-invasive monitoring. It is also likely 
that simply assuming a lag/bias relationship between the measured and underlying 
data would be too simplistic, and would not lead to sufficiently accurate 
interpretations of data generated from tear film measurements. 





Figure 5.1: A Gaussian pulse of blood-analyte concentration and the 
‘measured’ tear-analyte concentration based on four combinations of 
metabolic and loss profile: (a) 0th order – 0th order, (b) 1st order – 0th order, 
(c) 0th order – 1st order, (d) 1st order – 1st order. For each example, faster 
and slower rates are considered for both metabolism and loss. 
A simplified formulation of the problem considers a naïve case of 0th or 1st order 
metabolism directly from blood biomarker to non-invasive biomarker, with no 
additional time delay. Once the analyte enters the non-invasive medium it is 
assumed to evaporate or filter out, either at a constant rate or a rate proportional to 
its concentration (equivalent to a 0th or 1st order metabolic pathway respectively). In 
this example, an arbitrary input profile – a normal distribution – of blood-analyte is 
traced through the 0th or 1st order metabolic pathway into the tears, and, by 
considering its subsequent 0th or 1st order loss-profile, a prediction of the tear-
analyte concentration is generated. This process is shown schematically in Figure 
5.1; for each example, fast and slow metabolism and loss rates are considered, 
analogous to four patients with differing physiologies. The first conclusion is 




immediately obvious – even in this simple case, it is not possible to measure non-
invasive biomarker concentration and expect to accurately reconstruct the 
underlying blood biomarker concentration without some form of mapping function 
(this problem is well described in [7]); and, a lag/bias treatment, in which measured 
data is corrected for both time-delay and magnitude bias, is unlikely to be sufficient 
– a conclusion supported by analysis of this problem in the literature [105]. It is also 
clear that a faster or slower metabolism, and faster or slower loss from the non-
invasive medium, drastically alters the ‘measured’ concentration profile. Thus, an 
attempt to reconstruct the underlying input profile using inaccurate metabolic 
parameters (perhaps applying data taken from one patient to a different patient) may 
reach very incorrect conclusions. 
However, even this example is vastly simplified. In a real patient, the mathematical 
mapping of measured non-invasive biomarker concentration to underlying blood 
biomarker concentration will be far more complex, due to the physiology of each 
patient’s analyte absorption from the blood stream, enzymatic activity, kidney health, 
or even the architecture of their tear glands; all of these may complicate the 
mapping from underlying profile to measured data. It therefore seems that the best 
way to approach the reconstruction of underlying concentration profiles is an 
empirical process which learns, for each individual, their personal metabolic 
mapping for the analyte and measurement in question. 
Two types of data were used in this study. For the first, glucose data from real 
patients was obtained from [106]. This is a set of 31 patients, whose ISF glucose 
was monitored over a 12 hour period using a continuous glucose monitor (CGM). 
For the purpose of this study, this continuous data was treated as the blood glucose 
data (for this analysis the ISF glucose has sufficiently similar features to that of 
blood glucose), and an accepted two-compartment model [7,107] was used to 
generate paired ISF data (Figure 5.2 a). The two-compartment model is well 
described in the literature, but it is worth noting here that it is closely related to the 
1st order – 1st order case shown in Figure 5.1 d; effectively, the model describes the 
relationship of the ISF glucose to the blood glucose as an equilibration response, 
with characteristic time constant τ. Patients generally exhibit a range of time 
constants characterizing the transfer rate from blood glucose to ISF glucose; for this 
data, a time constant of τ = 20 mins was chosen (near the maximum of observed 
rates [7]). Of the 31 patients, 12 with statistically similar mean and maximum 




glucose levels were selected (since in this study these 12 patients are treated as the 
same patient on 12 different days). One of these sets was used for training, one for 
cross validation (CV), and 10 for test sets. 
 
Figure 5.2: CGM and simulated data. (a) CGM glucose data (‘BG’) with paired 
ISF glucose data (‘ISFG’) generated by a two-compartment model. (b) 
Simulated blood biomarker data (‘Underlying’) with paired non-invasively 
measured biomarker data (‘Measured’). 




In CGM monitoring, the Mean Absolute Relative Difference (MARD) is often used to 









𝑖=1  .       (5.1) 
The average MARD in these sets before correction was 6.7%. 
Next, to test the neural network method further, data was simulated which was more 
volatile than the real glucose data, and with a greater relative disparity between the 
non-invasive and blood biomarker measurements. The underlying (blood) data was 
constructed using a simple random walk, modified to walk preferentially towards 
zero 
𝑦𝑖 ∶= 𝑦𝑖−1 + 𝑟𝑎𝑛𝑑(−0.7 → 0.3),      (5.2) 
with values generated below zero set to zero before the next iteration. A series of 
coarse and fine smoothing functions were applied, so that the peaks and troughs 
reflected approximately the expected timescale of a particularly volatile biological 
marker, changing over the course of minutes. The data was scaled to an arbitrary 
maximum magnitude of ten simply to reflect the fact that biological data usually does 
not vary between zero and one. 
The metabolic shift was chosen to represent a number of possible mathematical 
mappings working in concert. These were applied in the following order, starting with 
underlying data, U, and finishing with ‘measured’ data, M5: 
1. A time delay: 
 𝑀1(𝑡) = 𝑈(𝑡 + 𝑡𝑑𝑒𝑙𝑎𝑦)        (5.3) 
2. Reduce magnitude by a proportional factor: 
𝑀2(𝑡) = 𝑓1𝑀1(𝑡)        (5.4) 
3. Reduce magnitude by a square factor: 
𝑀3(𝑡) = 𝑀2(𝑡) − 𝑓2𝑀2
2(𝑡)       (5.5) 
4. Reduce magnitude by a cube factor: 
𝑀4(𝑡) = 𝑀3(𝑡) − 𝑓3𝑀3
3(𝑡)       (5.6) 




5. Add a pooling effect, here approximated by addition of an average of the last 
tpooling seconds: 
 𝑀5(𝑡) = 𝑀4(𝑡) + 𝑓4 (
𝑀4(𝑡−1)+⋯+𝑀4(𝑡−𝑡𝑝𝑜𝑜𝑙𝑖𝑛𝑔)
𝑡𝑝𝑜𝑜𝑙𝑖𝑛𝑔
)    (5.7) 
By generating the underlying data in a pseudo-random way, the neural network 
gains no information from the underlying data – it cannot simply learn the standard 
patterns, and so must approximate only the metabolic mapping function. This 
mapping, with appropriately chosen factors, resulted in a ‘measured’ data set 
derived from the underlying data in a non-trivial manner (Figure 5.2 b). In these 
simulated data sets the concentrations were designed to vary near or at zero, which 
is represented physiologically in some biomarkers. Since MARD is not applicable in 
cases where data points vary around zero, a slightly adjusted metric was used, 




∑ |𝑦𝑖,𝑢 − 𝑦𝑖,𝑚|
𝑛
𝑖=1  ,      (5.8) 
where yu is the underlying data and ym is the measured data (or another data set in 
question). The average MAND in these sets before correction was 46.9%. 
A common correction used in cases of measurement disparity such as CGM is 
lag/bias correction, in which a lag (time delay) and bias (magnitude correction) is 
estimated and corrected for [105]. A lag/bias correction, in which lag and bias values 
were estimated via an iterative method for each data set, was applied to both data 
types, and MARD or MAND values from this correction method were used as a 
benchmark from which to compare the neural network method’s performance. 
Examples of the lag/bias corrected data is shown in Figure 5.3, and more 
information can be found in Appendix 12.1. 





Figure 5.3: Lag/bias correction in CGM and simulated data sets. (a) CGM 
Test Set 5 illustrating blood glucose (‘BG’), ISF glucose (‘ISFG’) and a 
lag/bias correction. (b) Simulated Test Set 3 illustrating simulated blood 
biomarker data (‘Underlying’) with paired non-invasively measured biomarker 
data (‘Measured’) and a lag/bias correction. Other lag/bias corrected sets 
found in Appendix 12.1. 





Figure 5.4: Schematic representation of the neural network, illustrating the 
three-layer nodal structure, the interconnections, and the hyperbolic tangent 
activation function used in the hidden layer. 
A simple neural network was created with 300 input nodes, 30 output nodes, and a 
hidden layer of 165 nodes (the arithmetic mean of the input and output) (Figure 5.4). 
Input and hidden layers were also given a bias node. Hyperbolic tangent activation 
functions were used for the hidden layer; in a ‘vanilla’ neural network sigmoid 
functions are used, but in this case they had a tendency not to fit the mapping well 
without the ability to vary below zero. The data was split into windows of length 
3,000 seconds (50 minutes); windows were created at 5 second intervals through 
the data. This window size was chosen in order to strike a balance between two 
factors: there must be sufficient data within the window for the neural network to 
learn the mapping, but the larger the window, the longer the initial measurement 
time before the network can begin predicting the underlying data. In addition, the 
window technique breaks up the natural patterns which might occur in real 
physiological data; this encourages the network to learn the mapping, not the 
patterns, which could otherwise lead to incorrect predictions in the case of a 
disruption to the underlying physiological process. The window separation of 
5 seconds was simply chosen to manage data quantity. The input to the neural 
network, for each window, was the 3,000 seconds of ‘measured’ data, averaged in 
batches of 10 to give 300 data points, while the output of 30 neurons was compared 




to 3,000 seconds of underlying data, averaged in batches of 100 to create 30 data 
points. This comparison yielded a cost function representing a measure of how well 


















𝑗=1 ) , (5.9) 
where indices 𝑖, 𝑗, 𝑘 and 𝑙 correspond to input, hidden and output layer, and training 
examples respectively, m is the number of training examples, I is the number of 
input neurons, h the number in the hidden layer, n the number in the output layer, a3 
is the set of neuron values in the output layer, y is the underlying data against which 
the prediction is compared, θ are the weights between neurons and λ is the 
regularization function. Regularization in the form of ridge regression of the weight 
values (θ) was used to avoid overfitting the training set. The regularization 
parameter λ was determined by training the neural network with a range of λ values 
(λ = 0, 10-4, 10-3, … , 103) and analysing training and CV cost for each value of λ to 
find the minimum. 
Each individual window (nearly 8000 in total) was treated as a separate training 
example. Training of the neural network was enacted using a backpropagation 
algorithm, in which the network’s output is compared to each training example, 
derived from the supervisory (underlying) data, and the difference at each output 
node is evaluated and used to compute a small change to each weight value within 
the network. This process is carried out iteratively until the inter-iteration variation 
approaches zero. Once the neural network is trained, this mapping would be carried 
out continuously throughout the day; every five seconds (in this case), the last 50 
minutes of data may be fed into the trained neural network to update its 
reconstruction of the underlying data. This method also allowed a significant number 
of training examples to be created from only one day of data. 
A basic regularized linear regression function was used to minimize the cost 
function, and backpropagation was used to train the neural network, yielding 
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with symbols defined as before. These gradients were used to update the weights 
after each training iteration, using a learning rate α.  
The CGM data set was trained for 3,000 iterations with hyperparameters of: learning 
rate α = 0.02, regularization λ = 10-3. The simulated data set was trained for 3,000 
iterations with hyperparameters of: learning rate α = 0.03, regularization λ = 10-2. All 
code was written in the GNU Octave programming environment, version 4.2.1; 
statistical methods such as ANOVA were performed in Microsoft Excel 2013. 




5.2 Results and Discussion 
For both CGM and simulated data, the neural network was trained as described in 
Section 5.1. The trained neural network was then applied to a series of test sets, 
and given only the ‘ISF Glucose’ or ‘Measured’ data respectively. It generated (for 
each window) an output which attempted to reconstruct the ‘Blood Glucose’ or 
‘Underlying’ data. The individual windows were used to rebuild the entire day of 
data, to better analyze the results. MARD or MAND scores were calculated in order 
to characterize the performance of the neural network reconstruction in comparison 
to a lag/bias method, and the original measurement (Tables 4.1 and 4.2). 
Table 5.1: CGM data, mean absolute relative difference in measured, 
lag/bias corrected, and neural network corrected cases. Colour scale 
from red to green indicates high and low values within this table. 








Training 8.4% 5.0% 2.4% 
CV 6.7% 3.0% 2.6% 
Test 1 4.6% 7.0% 4.0% 
Test 2 5.9% 5.9% 2.2% 
Test 3 9.1% 3.9% 2.5% 
Test 4 8.1% 4.9% 2.8% 
Test 5* 5.2% 2.5% 1.2% 
Test 6 7.9% 5.5% 5.5% 
Test 7* 4.2% 2.3% 1.4% 
Test 8 5.4% 2.8% 2.0% 
Test 9 7.6% 3.2% 2.6% 
Test 10 7.7% 6.3% 4.8% 
Average 6.7% 4.4% 2.8% 
 





The neural network method significantly improved on the measurement in the CGM 
data (MARD improved from 6.7% to 2.8%; using ANOVA analysis to investigate 
significance of difference of means, p = 1.6×10-6) and the simulated data (MAND 
improved from 46.9% to 4.8%; p = 1.1×10-18). In both cases, the neural network 
method also significantly outperformed the lag/bias correction (CGM: MARD 
improved from 4.4% to 2.8%; p = 1.8×10-2; simulated: MAND improved from 21.2% 
to 4.8%; p = 1.1×10-8). International standards provide guidelines on measurement 
fidelity: e.g. in glucose monitoring, ISO 15197 calls for 95% of measurements to fall 
within 20% of measured glucose value (if value > 75 mg dl-1) or within 15 mg dl-1 (if 
value < 75 mg dl-1), although, typically, modern devices improve on this standard.  
Table 5.2: Simulated data, mean absolute normalised difference in 
measured, lag/bias corrected, and neural network corrected cases. 
Colour scale from red to green indicates high and low values within 
this table.  









Training 47.2% 21.6% 3.9% 
CV 46.0% 20.0% 5.7% 
Test 1 47.1% 26.5% 5.3% 
Test 2* 48.0% 17.4% 4.0% 
Test 3* 46.6% 18.5% 3.8% 
Test 4 46.3% 21.5% 6.2% 
Test 5 47.1% 23.1% 4.7% 
Average 46.9% 21.2% 4.8% 
 





Figure 5.5: MARD/MAND values for CGM and simulated data sets. 
Significances of difference between measured and neural network corrected 
sets, and lag/bias and neural network corrected sets, are indicated. 
Both of the data sets investigated here achieved accuracies well within this value, 
and, significantly, in the simulated data the neural network correction greatly 
improved measurement fidelity from outwith the standard to well within, while the 
lag/bias correction did not achieve the standard (Figure 5.5). 





Figure 5.6: Neural network corrections for CGM data set. (a) CGM Test Set 
5 illustrating blood glucose (‘BG’), ISF glucose (‘ISFG’) and the reconstruction 
from the trained neural network; (b) CGM Test Set 7. Other test sets found in 
Appendix 12.2. 
 





Figure 5.7: Neural network corrections for simulated data set. (a) Simulated 
Test Set 2 illustrating simulated blood biomarker data (‘Underlying’) with 
paired non-invasively measured biomarker data (‘Measured’) and the 
reconstruction from the trained neural network; (b) Simulated Test Set 2. 
Other test sets found in Appendix 12.2. 
In general, smoother varying features were well reconstructed by the neural network 
method (e.g. Figure 5.6 a, t = 30,000 to 40,000). Features in the underlying data 




which exhibited sudden discontinuity or volatility were not so well reconstructed (e.g. 
Figure 5.6 b, t = 30,000). In particular, the sharper peaks and troughs exhibited in 
the simulated data (e.g. Figure 5.7 a, t = 20,000 to 35,000) were not always followed 
by the reconstruction. This is due at least in part to the architecture of this particular 
neural network, since a small error is usually incurred due to the simplification of the 
output data, and again from the averaging functions during rebuilding of the data 
set. A larger network – in particular, more output neurons – would avoid these 
errors, at an increased computational cost. 
It is notable that the neural network method has increasing utility with increasing 
difference between measurement and underlying data, particularly in comparison to 
the lag/bias correction method. Although non-invasive medical devices of this class 
are still largely in the research stage, it will be of great importance to have available 
a measurement correction method which is able to encompass the additional 
complexity of larger shifts than have been observed in CGM, both in clinical use and 
at the research level. Understanding the data handling methods in advance can 
inform device and experimental design, raising or answering questions about patient 
use protocols and target (and redundant increases in) sensor performance. For 
example, this correction method was achieved with only 12 hours of supervised 
training, a reasonable set-up time for a patient, and the training time may be further 
reduced by ‘priming’ the neural network with initial neuron parameters, or pre-
training on a previous patient’s data, such that only fine-tuning is required. However, 
further investigation is required into the effects of covariate factors, such as the 
increase in cortisol observed with an increase in blood glucose [108]. Devices with 
multimodal sensing capability can obtain information about multiple biomarkers at 
once [49], and this data may be incorporated into an updated version of this neural 
network method. In the case of covariate factors, it may be necessary to develop a 
training protocol which accounts for the various features, e.g. including a high-
glucose meal during training. 
In medical devices with even a small discrepancy between the measured and 
underlying data, measurement distortion causes significant problems. For example, 
minimally-invasive glucose sensing requires correction via mathematical modelling, 
which is not always accurate or patient-specific – studies call for frequent voluntary 
calibration using fingerprick measurements [105], reducing the benefit of a 
minimally-invasive method. Now, minimally- and non-invasive devices are 




increasingly the subject of research, or moving towards clinical use, with most non-
invasive devices (analyzing tears or other non-invasive media) likely to exhibit an 
even greater degree of measurement distortion than that found in ISF. The neural 
network tool described in this study is potentially able to learn an individual patient’s 
particular measurement distortion, without prior understanding of the form of this 
distortion, and subsequently correct for the difference in real time to give a 
reconstruction of the underlying data. 
5.3 Conclusion 
Reconstructing blood biomarker profiles from measurements taken in the tear film 
(or other non-invasive media) is a key part of obtaining data in an ESCL with real 
clinical utility. The problem is made difficult by the complexity of the difference 
between the measured data and the underlying data, resulting from the complexity 
and variability of physiological processes underlying the transport of analyte into the 
lachrymal fluid, and by the individuality of each patient’s physiology. In this chapter, 
a method based on a neural network was demonstrated which can learn the 
correction required in a particular patient, potentially after only one day of 
supervised training, and subsequently reproduce the underlying blood biomarker 
profile with fidelity well within ISO requirements for glucose monitoring. The benefits 
of using a neural network method include the generic nature of the approach; i.e. it 
is not necessary to specify the type of biomarker being measured, or the method of 
non-invasive measurement. This method is therefore applicable to ESCL 
measurements and other non-invasive devices such as smart tattoos performing 
continuous measurement on the skin. 
There is currently no method described in the literature which accounts for the 
problem of measurement distortion in ESCLs. It was therefore of great importance to 
explore solutions to the problem, in order to confirm the potential utility of an ESCL 
in the first place, and to inform the design of a next-generation ESCL. From this 
study it is clear that measurement distortion may be corrected for using a neural 
network method, and that, in combination with the spatiotemporal method described 
in Chapter 3, ESCLs may be used to produce electrochemical measurements of real 
clinical utility. 
  









6 Spatiotemporal Electrochemical Sensing in a Smart 
Contact Lens 
 
An ESCL device was designed, following the findings in Chapters 2-4, and 
incorporating (or using updated versions of) techniques from each. From Chapter 3, 
the fabrication method of the core gold/polyimide device was employed in the first 
stage of this device, with minor modifications in some of the cleanroom techniques. 
Parasitic capacitance, induction and resistance from the long meandering gold wires 
were found to be detrimental to the electrochemical signal, increasing signal-to-
noise ratio (SNR), so shorter, straight wires were used in the new design in order to 
reduce these effects. Similarly, in Chapter 4 the use of a connected array of micro- 
or nanoelectrodes led to a better signal than the single microelectrodes found in 
Chapter 3; thus, connected arrays of microelectrodes were designed in order to 
draw more current and improve SNR. In Chapter 5, the algorithm described required 
continuous time-series concentration data, informing the measurement technique 
used for the ESCL device. It was also conjectured that, with more information about 
the introduction, progress and drainage of the tear fluid in the eye, the correction 
algorithm would be better able to reconstruct the underlying concentration found in 
the blood. Thus, working electrodes were placed in each quadrant of the eye to help 
monitor the tear flow relative to the lachrymal glands and the lachrymal puncta. 
In this chapter the design and fabrication of the ESCL device is described, with 
further discussion on the challenges facing safe clinical use, and some potential 
solutions to these challenges. The sensing performance of the device is 
characterised, and an updated version of the fast-switching chronoamperometric 
method is described. Using this technique, spatiotemporal electrochemical sensing 
is demonstrated in various environments including a model eye, in which flow of a 
high-concentration fluid entering the model eye, flowing across the surface, and 
draining out, is monitored at real-speed.  
This chapter presents work some of which has been published in peer-reviewed 
articles [16]. 






Figure 6.1: Schematic showing key aspects of the design of the ESCL device. 
This ESCL (Figure 6.1) consists of a core device – comprising a layer of gold 
(100 nm in thickness, with a 50 nm titanium-tungsten adhesion layer), sandwiched 
between two layers of polyimide (each 5.5 μm in thickness) – which is encapsulated 
in two layers of TPU (each 100 µm in thickness), and moulded to a spherical cap 
shape (radius of curvature 9 mm). Gold wires connect the four working electrodes 
and the counter electrode to a ZIF (zero insertion force) connector. Each working 
electrode is comprised of a connected array of microelectrodes (Figure 6.1, inset). 
In this study the device was placed on a hydrogel contact lens to illustrate intended 
use (Figure 6.2 a); further work would be required to develop processes for 
complete integration into a soft hydrogel platform. The device is flexible and robust 
to folding (Figure 6.2 b), returning to its original shape after repeated mechanical 
deformation.  
The ESCL consists of a set of four individually addressable microelectrode arrays, 
with one placed in each quadrant of the device (Figure 6.1, Figure 6.2 c). Each is 
situated next to one of four counter electrodes (Figure 6.2 d), which share a single 
electrical connection. (An external reference electrode was used in this study.) Each 
microelectrode array comprises 33 microdisc electrodes of 30 μm diameter, spaced 
at 30 μm in the planar orthogonal directions, in an offset grid of a custom shape 
(Figure 6.2 d). The shape of the microelectrode arrays was chosen to optimise 
spatial efficiency and reduce deviation from the design area. 





Figure 6.2: Images of the ESCL device. (a) Photograph of the ESCL device 
illustrating placement on a contact lens; (b) photograph of the ESCL 
undergoing mechanical deformation using tweezers. (c) Photograph of an 
unmoulded ESCL, illustrating material regions. Working electrodes 1-4 are 
indicated by W1-4; (d) photo micrograph of working electrode 3 (W3). 
The close proximity of the microdisc electrodes within each array is such that, at 
longer time scales of continuous current flow, the individual diffusion fields overlap 
and reduce the sensing performance of the system (i.e. after diffusion field overlap 
the sensor performs akin to a larger electrode comprising the entire area of the 
array). An estimate of this time scale can be made using Fick’s law, with overlap 





 ,         (6.1) 
Where Ldiff is the characteristic size of the diffusion field and D is the diffusion 
coefficient of the redox species (here ferrocenemethanol is used, with a value of 
D = 5×10-10 m2 s-1 [47]. (For a physiological comparison, cortisol has a diffusion 
coefficient of Dcortisol ≈ 2.9×10-10 m2 s-1 [109]). Using Ldiff = 15 μm, a value of 
tov ≈ 225 ms is found. The fast-switching chronoamperometric technique used in this 




study addresses each working electrode for less than 50 ms at a time. Thus, the 
microdisc spacing is sufficient to achieve microelectrode-like sensing characteristics 
during intended use. 
Previous work has shown that serpentine connections reduces buckling behaviour in 
the substrate after thermoforming [19,93]; however, since these were only 
necessary in the radial direction, the design area was restricted to a narrow ring in 
the circumferential direction of the lens. Earlier work (described in Chapter 3) also 
highlighted the necessity of reducing parasitic capacitance, inductance and 
resistance in an ESCL device [49]; using non-meandering connections to the 
electrode sites, these effects were significantly reduced. Straight connections were 
also more spatially efficient, and therefore reduced the physical footprint of the 
device – this reduction is likely to improve comfort during normal use. 
In practice, oxygen permeability is a key factor in contact lens comfort and safety. 
Modern contact lens materials are highly oxygen-permeable [32], and, unlike many 
reported ESCL prototypes, the ring-shaped design of this ESCL leaves the majority 
of the lens area free from non-oxygen-permeable materials, allowing sufficient 
oxygen transfer to the eye for safe extended use. 
In this study a ZIF connector was used to provide and electrical interface to the 
device; placement of a thinned silicon chip has been described in previous work 
[19,28,62], and this ESCL is intended to incorporate wireless function once sensing 
protocols have been established. Using an antenna to harvest power inductively 
[62], power transfer of greater than 100 µW has been demonstrated [23], and new 
flexible battery technologies developed for smart contact lenses also lead to 
stringent power requirements [33]. Thus, a balance was required in designing the 
microelectrode arrays: increased current reduces the required sensitivity of the 
potentiostat system, and can lead to a more robust and compact chip design, and 
increase the signal to noise ratio. However, higher current leads to increased power 
requirements. Using previous results as a guide (Chapter 3), it was calculated that 
the fast-switching chronoamperometry sensing protocol drew an average of 
approximately 1 µA, including parasitic circuit effects (but not including sensor-
driving electronics). At 0.4 V, this leads to an estimated power consumption of 
approx. 13.5 µW with 33 arrayed microdisc electrodes – that is, similar to the power 
transfer to the active element demonstrated by Pandey et al [23] (where the power 
consumption of the remaining architecture accounted for approximately 100 µW). 




However, the design of the gold wires in the ESCL device significantly reduced 
these parasitic effects, and in fast-switching chronoamperometry the microelectrode 
arrays draw only approx. 40 nW (Section 6.4). Therefore, the new system falls very 
comfortably within the power requirements of current SCL platforms. 
 
Figure 6.3: Illustration of fluid flow in the eye. (a) Illustration of the anatomy of 
the eye, and the placement of the ESCL on the corneal surface. The arrow 
indicates overall flow of tear film from source to drain. Some parts of this 
figure reproduced from Gray's Anatomy, Plate 896; (b) schematic illustration 
of a three-compartment model of lachrymal fluid introduction, progress and 
drainage. 
Placement of the electrodes in each of the four quadrants of the ESCL was chosen 
to investigate the flow of chemical markers across the cornea, with reference to the 
position of the tear film source (the lachrymal ducts) and drain (the lachrymal 
puncta) (Figure 6.3 a). With spatially distributed sensing, more information about the 
introduction, progress and drainage of chemical markers in the lachrymal fluid may 
be gathered. For example, W1 might measure an increased concentration in new 
lachrymal fluid as it enters the eye; W4 and W2 provide information on the bulk tear 
fluid (i.e. within the lachrymal lake); and W3 provides information on the 
concentration at the point of drainage. Using these data and an appropriate three-
compartment model, as shown schematically in Figure 6.3 b, an estimation can be 
made of the current concentration level in the lachrymal glands, giving the earliest 
possible indication of changes of the concentration in the rest of the body 
(particularly in blood). Earlier ESCL prototypes have struggled to measure markers 
(such as glucose) with sufficient fidelity and speed to make useful estimations of 




current blood glucose levels [58]; using this spatiotemporal method, it may be 
possible to improve measurement fidelity sufficiently to make accurate diagnostic 
conclusions, and even early-warning health monitoring systems, using an ESCL. 
 
Figure 6.4: Scanning electron micrograph of a working electrode site. 
Previous ESCL designs have not explicitly reported on the question of efficient tear 
film contact with the electrochemical sensors, generally assuming instead a bulk 
fluid scenario. However, integration of a device such as this into a contact lens likely 
entails encapsulation in hydrogel or a similar material. In addition, it is currently 
unclear whether the best position for the sensors is out- or in-facing. The current 
model of the tear film describes a bi-layer structure, with a thin superficial lipid layer 
and an aqueous/mucin gel layer with decreasing mucin content from the corneal 
surface to the lipid layer [51], and it is not currently understood exactly how the 
addition of a contact lens affects this structure. It is possible that different analytes 
may variously be better represented on either the out- or in-facing side of the lens, 
depending on their representation in each fluid environment (i.e. aqueous, mucosal 
or lipid), and therefore two classes of ESCL or a combined lens may be necessary. 
Corneal irritation must be considered in the in-facing case. In this ESCL, the sensing 




sites are recessed 100 µm into the TPU surface (Figure 6.4), which is greater than 
the estimated depth of the tear film (40 µm [110]), and it is not yet known whether 
this architecture would cause irritation or discomfort if placed in direct contact with 
the ocular surface. In this study both in- and out-facing lenses were moulded, and 
no difference in performance was observed. The out-facing lenses were estimated 
to be more suited to the ocular environment, and this architecture is also less likely 
to cause irritation in the eye. However, in-facing sensors may experience less 
interference from environmental effects such as rain and humidity. A more in-depth 
investigation into this question may be useful on the route to clinical use, though it is 
outside the scope of this particular thesis. 
6.2 Fabrication 
 
Figure 6.5: Diagrammatic representation of fabrication steps. (a) Polyimide 
and TiW/Au layers on a glass wafer; (b) S1818 resist patterned to define 
metal layers; (c) metal layers defined by wet etching and stripping of 
photoresist; (d) polyimide layer spin-coated over metal layers; (e) thick 
photoresist (AZ4562) patterned to define contact pads and electrode sites; (f) 
after reactive ion etch and stripping of photoresist, a picosecond laser is used 
to cut out the device; (g) device released from glass wafer; (h) pre-patterned 
thermoplastic polyurethane bonded on either side of the device, and device 
cut to shape using a picosecond laser; (i) device thermoformed to a spherical 
cap shape and added to hydrogel contact lens. 
The device fabrication process is illustrated in Figure 6.5 and described below. The 
glass wafer was cleaned and treated with a chemical adhesion promoter ((3-
Aminopropyl)triethoxysilane, APTES), then a layer of polyimide (5.5 μm thickness, 




PI-2611, HD Microsystems) was spin-coated onto the wafer (3000 rpm, 30 s), dried 
on a hot plate (200 °C, 10 min) and cured in a nitrogen oven (RT to 200 °C at 4 °C 
min-1; 20 min at 200 °C; ramp to 350 °C at 2.5 °C min-1; 60 min at 350 °C). 
Photolithography (S1818 photoresist, spin coating at 4000 rpm for 60 s, baking at 
90 °C for 2 min, UV irradiance for 85 mJ cm2, developing for 30 s with developer 
MF-319/deionized water (DI H2O) at 1:1 ratio) was used to cover the central working 
area of the mask, while reactive ion etching (RIE) (1 min, 150 W, 150 mTorr, 
15 sccm O2, 5 sccm CHF3) was used to roughen the exposed perimeter area of the 
polyimide before removal of the photoresist (1 min in acetone, 1 min in 
acetone/isopropyl alcohol at 1:1 ratio, 1 min in DI H2O). A second layer of polyimide 
was spin-coated (same parameters as before). The second layer of polyimide 
adhered strongly to the roughened perimeter area of the first layer of polyimide, but 
not strongly to the smooth central area. This ensured easier release of the devices 
(restricted to the central design area) after fabrication, while avoiding delamination 
of the second polyimide layer during processing. 
 Metal layers of TiW (50 nm, adhesion layer) and Au (100 nm) were deposited by 
sputtering. These metal layers were patterned with photolithography (S1818 
photoresist) and wet etching. A second layer of polyimide was added as described 
above. Thick photoresist (AZ4562, target thickness 10 μm) was used as a hard 
mask to define contact pads and electrode sites, and reactive ion etching (45 min, 
22 sccm O2, 5 sccm N2, 350 mTorr, 75 W; or using parameters previously described 
in Chapter 3 and [49]) was used to etch the top layer of polyimide through to the 
gold layer. The photoresist was stripped and the devices cut out using a picosecond 
laser (355 nm, 12 ps, 50 kHz, 320 mW). The devices were then released from the 
glass wafer using thermal release tape. Thermoplastic polyurethane was pre-
patterned with the picosecond laser (355 nm, 12 ps, 50 kHz, 400 mW, 10 passes at 
40 mm s-1), creating vias at the electrode sites and contact pads. These pre-
patterned sheets were bonded to either side of the devices with a custom two-step 
method using a wafer bonder. The encapsulated devices were once again cut out 
using the picosecond laser (same parameters as previous step) and moulded into a 
hemispherical cap shape with thermoforming. 





Figure 6.6: Fouling of the electrode surfaces. (a) Photo micrograph of an 
electrode site with misaligned TPU top layer. (b) Photo micrograph of a 
misaligned electrode site on a different device, where TPU spray from the 
laser excision is observed. (c) Photo micrographs showing fouled electrode 
sites before and (d) after reactive ion etching, a process which cleans the 
electrode surfaces of deposited TPU matter. 
In some devices, the top TPU layer was either partially or catastrophically 
misaligned (Figure 6.6 a shows an example of a catastrophic misalignment, in which 
some part of the microelectrode array is covered, while Figure 6.6 b-d shows partial 
misalignment). In all of these cases, the laser excision of the device, designed to cut 
through both layers of TPU, usually cuts into the window in which only a single layer 
of TPU exists. In some cases, this caused no issues (e.g. Figure 6.6 a), while in 
other cases the laser caused dispersion of the TPU matter away from the excision 
line, often covering the electrode surfaces (e.g. Figure 6.6 b). Although we did not 
use devices in which significant physical fouling was observed for electrochemical 
testing, it is possible that some small quantity of TPU dispersion occurs even when 
not easily observed, and possibly even without misalignment. Since this would 
happen to varying degrees at different electrode sites on a single device, the result 
may be an intra-device variation of electrode performance, which was indeed 
observed in Figure 6.7 (Section 6.3).  Although in the scope of this thesis it was not 




necessary to address this effect in more detail, a method was sought to clean the 
surface in case of future fouling issues; reactive ion etching (5 min, 20 sccm O2, 
150 mTorr, 40 W) was successfully used to remove the residual TPU from the 
surface of the electrodes (Figure 6.6 c-d). 
6.3 Electrochemical Characterisation 
For electrochemical measurements, ferrocenemethanol (Aldrich, 97% purity) was 
prepared in various concentrations in 0.1 M potassium chloride (Aldrich, 99% purity) 
with deionised water. All devices were electrochemically cleaned in H2SO4 with 5 
cycles of cyclic voltammetry (0 V – 1.6 V – 0 V). Electrochemical experiments were 
carried out in a Faraday cage using an Autolab PGSTAT128N potentiostat, using 
the on-device gold counter electrode and an external Ag/AgCl reference electrode 
(BASi, USA). Control and data acquisition was performed using Nova 2.0.1. 
 
Figure 6.7: Electrochemical characterisation of the microelectrode arrays. (a) 
Cyclic voltammograms of each working electrode in a single lens; (b) cyclic 
voltammograms taken before and after moulding; (c) cyclic voltammograms 
taken before and after repeated mechanical deformation; (d) current 
response to a range of concentrations of FcMeOH. 
Electrochemical characterisation was carried out using standard cyclic voltammetry 
(0 V – 0.5 V – 0 V, at 0.1 V s-1), in 0.5 mM ferrocenemethanol (FcMeOH) – a redox 




reporter which exhibits well-characterised electrochemical behaviour at bare metal 
electrodes, and is often used to investigate electrochemical systems. The 
microelectrodes showed expected sensing characteristics in these experiments; 
however, it is worth noting that these arrays were designed for high-speed sensing 
protocols (Section 6.1), and therefore diffusion field overlap may result in reduced 
sensitivity during these standard tests. 
Variation in current response between the different electrode sites was observed 
(Figure 6.7 a). In earlier work, the effect of surface roughness was quantified and 
discussed ([49], Chapter 3), and the intra-lens variation here is likely due in part to a 
non-uniform reactive ion etch profile during fabrication (faster etch speeds were 
observed at the periphery of the wafers than at the centre), which resulted in higher 
surface roughness in some electrodes. In addition, misalignment of the TPU 
windows caused physical fouling of the electrode surfaces during the last laser 
excision stage in some electrode sites, and to varying degrees between electrode 
sites (Section 6.2), which may also account for the observed variation. This variation 
is corrected for during normalisation in the high-speed chronoamperometric sensing 
protocol. 
Sensing performance before and after thermoforming was investigated, and no 
significantly measurable difference was found between the two states (Figure 6.7 b). 
Similarly, sensing performance was unchanged after repeated mechanical 
deformations (Figure 6.7 c; ten full folds of the lens, as illustrated in Figure 6.2 b). 
The position of the metal layer in the neutral mechanical plane reduces stress during 
mechanical deformation to a minimum and avoids cracking or damage to the wire 
tracks. 
Comparison of these results to an established theoretical model of microdisc 
electrodes was carried out using the Saito equation (equation 6.2) [95], which 
calculates limiting current under steady-state conditions: 
𝑖𝐿  =  4𝑛𝐹𝐷𝑐0𝑟 ,        (6.2) 
where n is the number of electrons transferred in the reaction, F is the Faraday 
constant, D is the diffusion coefficient of the redox species (FcMeOH), c0 is the 
concentration, and r is the radius of the microdisc. Values of D = 5×10-10 m2 s-1 [47], 
and c0 = 0.5 mol m-3 were used. In addition, theoretical models suggest that the 
recession of a microdisc electrode of radius 15 µm into the polyimide by 5.5 µm will 




result in a reduction in current drawn by 32% [94]; this correction was included in the 
analysis. A mean limiting current from the four electrodes was found to be 
3.01×10-8 A, which in this model yields a microdisc radius of 13.8 µm (for an array of 
33 microdiscs). This is slightly smaller than the true size, a reduction which may 
result from physical fouling of some of the electrode surfaces by TPU during the last 
laser excision stage (Section 6.2). 
Cyclic voltammetry was also used to investigate linearity of the current response to 
a range of concentrations of FcMeOH, from 10 to 500 µM, and a ‘blank’ 
measurement of KCl (0.1 M) (Figure 6.7 d). As found in Chapter 3, a linear current 
response was observed, with R2 > 0.99, indicating a high confidence in the linear fit. 
Limit of detection (LOD) was calculated following the IUPAC convention [98]: 
𝑥𝐿 =  ?̅?𝑏𝑙 + 𝑘𝑠𝑏𝑙        (6.3) 
where xL is the smallest current that can be reliably detected, ?̅?𝑏𝑙 and sbl are the 
mean and sample standard deviation respectively of the blank (KCl) measurement, 
and k is a numerical factor (k = 3 was used to ensure a confidence level of > 99%). 
The LOD is obtained by substituting x = xL into the calibration function (Figure 6.7 d), 
yielding the lowest detectable concentration at this confidence level. Despite the 
close proximity of the microdiscs in the array (Section 6.1), a LOD of 7.8 µM was 
calculated. This is a twofold improvement on previous results (Chapter 3), most 
likely due to the increased signal (and therefore higher signal-to-noise ratio) of the 
microelectrode array. 
6.4 Spatiotemporal Electrochemical Sensing 
During spatiotemporal sensing a 74HC4051 8-channel analog multiplexer, driven by 
a microcontroller (Arduino Nano [99]), was used to rapidly switch in sequence 
through the eight working electrodes (Figure 6.8). Data processing was carried out 
using algorithms written in the Python programming language. 
 





Figure 6.8: Schematic of the circuitry used for spatiotemporal experiments, 
illustrating the connections of the potentiostat (Autolab PGSTAT128N) to the 
working electrodes (W1-4), via an analogue multiplexer driven by a 
microcontroller (Arduino Nano); to the on-device counter electrode (C); and 
to the external reference electrode (R). 
 
Figure 6.9: Photograph of the eye model used in spatiotemporal experiments. 
To test the ESCL in a representative flow environment, an eye model was 
constructed using Newplast (modelling clay), silicone tubing and a polymer 
(polyoxymethylene) sphere (Figure 6.9). While a real eyeball has an overall radius of 
around 12 mm, contact lenses usually have radius of curvature closer to 9 mm to 
account for the shape of the cornea; thus, a sphere radius of 9 mm was chosen. 




During experiments, fluid was added via the fluid input tube (placement chosen to 
mimic the location of the lachrymal ducts), and drained through or over the fluid 
output tube (placement chosen to mimic the location of the lachrymal puncta). The 
surface of the eye model was irrigated before each experiment, both topically and 
through the fluid input tube. 
Spatiotemporal electrochemical sensing was performed using an updated version of 
the fast-switching chronoamperometric method described in Chapter 3. An analogue 
multiplexer driven by a microcontroller (Arduino Nano [99]) was used to address the 
working electrodes one-by-one in a cyclic sequence. Working electrode 1 (W1) was 
addressed for 60 ms, while W2-4 were addressed for 50 ms; this variation was used 
to tag W1 for easier signal separation. The sequence resulted in a frame rate of 
approximately 19 Hz (i.e. 19 electrodes per second). A potentiostat performed a 
chronoamperometric measurement (10 s, 0.4 V, 200 Hz sample rate) while the 
switching cycle repeated. In combination this produced a signal effectively 
consisting of a repeating four-step sequence of 50 ms (or 60 ms) 
chronoamperometric measurements (Figure 6.10 a). The 30-45 ms period within 
each measurement was isolated and, taking the arithmetic mean of the data within 
this period, a single current value was calculated at that time point (Figure 6.10 a). 
The time period was chosen to avoid non-Faradaic signal at the beginning of the 
chronoamperometric measurement and any switching noise at the end. For each 
experiment, a full (10 s) measurement was performed in 0.1 M KCl (a zero 
concentration measurement) and 0.5 mM FcMeOH (a high concentration 
measurement), before spatiotemporally-varying concentration profiles were 
investigated. Having established the linearity of the current-concentration 
relationship (for this range) in Section 6.3, these measurements were used to 
calibrate each electrode at each time point, as shown schematically in (Figure 
6.10 b). Since each electrode was updated every four frames, linear interpolation 
was used to avoid a rolling shutter effect. 
 





Figure 6.10: Illustration of the signal processing method, and the data 
produced. (a) Raw signal from fast-switching chronoamperometry in high 
concentration (‘FcMeOH’), zero concentration (‘KCl’) and varying 
concentration (‘KCl + FcMeOH’). Extraction of a single data point from each 
chronoamperometric sub-measurement is denoted by crosses; (b) calibration 
procedure using the extracted data points from (a), in which varying 
concentration measurements are compared with temporally-aligned high and 
zero measurements; (c) calibrated concentration data for each working 
electrode during a full 10 s experiment with varying concentration in a beaker. 
Two injections of FcMeOH into an initial volume of KCl are indicated. Inset: 
visual representation of the concentration at each working electrode, with 
concentration values represented by red colour shading (see Video 6.1). 




Compared to the flexible microelectrode array discussed in Chapter 3, the quality of 
the chronoamperometric signal (Figure 6.10 a) was greatly improved, both in terms 
of signal-to-noise ratio, and reduction in variation between the different working 
electrodes. This is due to the use of microelectrode arrays, which increase the 
signal without sacrificing the enhanced sensing properties of microelectrodes, and 
the reduction of parasitic capacitance, inductance and resistance in the device 
(Section 6.1). 
The result of this signal processing method is shown in Figure 6.10 c, in which time-
varying concentration data are shown for each working electrode during a beaker 
experiment. In this experiment, measurements were first performed in a beaker of 
KCl (0.1 M) and FcMeOH (0.5 mM) to produce calibration data as described above. 
Next, two 1 ml injections of FcMeOH (0.5 mM) were added to a beaker KCl (0.1 M, 
initial volume ~ 5 ml) during a 10 s measurement period. The effects of each 
injection are clearly visible in the plot, and the distribution of concentration across 
the device shows some spatial inhomogeneity resulting from the position of the 
ESCL in the beaker and the location of the pipette tip. At the moment of injection, 
the concentrations measured at each electrode are somewhat volatile (e.g. 
t = 7 to 8 s), reflecting agitation and bulk movement in the two miscible fluids. As 
time progresses subsequent to each injection, mixing effects begin to reduce the 
disparity in concentration between each working electrode (e.g. t = 9 to 10 s). 
To investigate the ESCL in environments more representative of the ocular surface, 
two more experiments were designed. Both experiments were performed multiple 
times, with representative results shown in Figure 6.11. As injection of fluid was 
performed manually, there was a large variation in the resulting data, as would be 
expected in the physiological case. For each experiment, at least two successful 
instances were carried out, with success being defined empirically and qualitatively 
as smooth injection of the correct quantity of fluid within the 10 s time frame, with no 
misalignment of the pipette or other components. 
In the first experiment, the device was placed on top of a droplet of KCl for a zero 
concentration calibration measurement, then FcMeOH for a high concentration 
calibration measurement, with electrodes facing down. After calibration, a time- and 
space-varying concentration was created by slowly injecting FcMeOH (~ 0.5 ml) into 
an initial droplet of KCl (~ 0.5 ml) at the W1 and W4 side of the ESCL (Figure 
6.11 a). By injecting the FcMeOH slowly, bulk mixing was kept to a minimum, and 




very little increase in concentration was observed at W2 and W3, while W1 and W4 
measured large changes in concentration. Flow of the droplet away from the ESCL 
towards the lower left direction during this experiment drew residual KCl into the W1 
region, which resulted in a transient reduction in concentration from t = 6 to 8 s. As 
injection continued, both W1 and W4 measured an increasing concentration, with 
diffusive effects beginning to reach W3 by the end of the measurement period 
(t = 9 to 10 s). 
 
Figure 6.11. Concentration data for each working electrode during droplet and 
eye model experiments. (a) Concentration data for each working electrode 
during a 10 s droplet experiment, in which FcMeOH was pipetted into an initial 
droplet of KCl. Inset: visual representation of the concentration at each 
working electrode, with concentration values represented by red colour 
shading (see Video 6.2); (b) concentration data for each working electrode 
during a 10 s eye model experiment, in which FcMeOH was introduced to the 
fluid input of the eye model after previous irrigation with KCl. Inset: visual 
representation of the concentration at each working electrode, with 
concentration values represented by red colour shading (see Video 6.3). 




In the second experiment, measurements were carried out on a model eye, built to 
mimic some aspects of the flow of tear film in the eye (Figure 6.9). While blinking 
effects and viscosity play key roles in the flow of the lachrymal fluid in a real eye, 
this experiment was designed as a proof of principle, to show that (a) spatial 
variation in concentration can be measured in a flow environment at a high rate of 
change, and (b) the ESCL can work effectively on the curved surface of a structure 
similar to the eye. Since little is known about the flow of tear film in the eye when a 
contact lens is worn, there may be diminishing returns in creating more ‘accurate’ 
eye models; a more informative next step would be to work in an animal or human 
model. 
FcMeOH was injected through the fluid input tube, located in a position analogous to 
the lachrymal ducts (Figure 6.11 b, see Figure 6.3 a). The flow of liquid was 
observed first at W1, then W4, at which point the fluid ran along the lower eyelid 
section of the model to the fluid output tube, located in a position analogous to the 
lachrymal puncta. Fluid was occasionally observed around the W3 region, although 
without blinking effects the transport of fluid to W2 and W3 was very limited. The eye 
model was irrigated with KCl before the input of FcMeOH; calibration from the 
droplet experiment was used to ensure a good fluid connection during those 
procedures. 
The data measured from the four working electrodes shows evidence of all 
empirically observed fluid flow effects. W1 quickly measured a concentration change 
(t = 2 s), and after an initially steep increase, continued to increase more slowly as 
residual KCl was flushed out (t = 7 to 10 s). W4 measured an increase in FcMeOH 
concentration after an additional delay (t = 2.5 s), and, since the fluid was flowing 
over a larger area after the initial injection point when compared to W1, measured a 
slower increase in local concentration (t = 3 to 5 s). W2 and W3 measured a slight 
increase in concentration on occasion, when fluid happened to flow away from the 
ordinary path (e.g. t = 6.5 s). 
In the eye model experiment, concentrations above the maximum (0.5 mM) were 
occasionally measured, which shows some limitations of the normalisation 
technique; namely, in a static setting (such as the droplet experiment, from which 
normalisation data was obtained), some FcMeOH depletion occurs in the local 
environment of the sensors over the 10 s measurement period, approaching a 
pseudo-steady-state condition with growth of a secondary diffusion region supplying 




the intermittent primary diffusion fields at each working electrode site (17% reduction 
in current during the first second of measurement, Figure 6.12). 
 
Figure 6.12: Mean current drawn from all working electrodes in both beaker 
and droplet high concentration calibration measurements 
([FcMeOH] = 0.5 mM). Initially the current decreases, while after 9 s the 
change in current is less than 0.5% s-1, indicating pseudo-steady-state 
conditions. 
However, in the (fast) flow environment of the eye model, fresh FcMeOH 
replenishes the supply in the diffusion region of the working electrodes in a flow-, 
rather than diffusion-mediated manner. Therefore, as the measurement continues, 
the data from the static experiment becomes increasingly less applicable to a fast 
flow experiment. However, real flow in the eye occurs at a mean rate of 1.2 µl min-1 
[111], although higher rates up to 7 µl min-1 may be observed during reflex tear 
production [55], and potentially even higher during blinking. These values are 
significantly below the approximate maximum flow rate of 3 ml min-1 generated in 
the model eye (chosen to test the performance of the lens in a particularly fast-
flowing environment), and is much closer to a static environment, with low rates of 
concentration change. In calibration data, a steady-state (change in current 
< 0.5% s-1) was reached within the ten second measurement period (Figure 6.12), 
and, with a mean tear film turnover of 16% min-1 [111], it is likely that a steady state 
calibration method would be appropriate for accurate measurements in the tear film 
under physiological flow conditions. 





Video 6.1. Electrochemical video in which a colour map representation of FcMeOH 
concentration is used to visualise spatiotemporal concentration variation during the 
beaker experiment (see Supplementary Materials). 
 
Video 6.2. Electrochemical video in which a colour map representation of FcMeOH 
concentration is used to visualise spatiotemporal concentration variation during the 
droplet experiment (see Supplementary Materials). 
 
Video 6.3. Electrochemical video in which a colour map representation of FcMeOH 
concentration is used to visualise spatiotemporal concentration variation during the 
eye model experiment (see Supplementary Materials). 
A spatiotemporal electrochemical measurement is intuitively visualised by an 
electrochemical video. For each experiment, the data were rescaled between 0 and 
1, and used to create a colour map, in which FcMeOH concentration is represented 




by the colour scale. These can be viewed in real time in Videos 1-3 (Supplementary 
Materials). These electrochemical ‘videos’ illustrate the various fluid effects 
discussed above.  
6.5 Conclusions 
A new ESCL has been designed and built, following SCL platform technology 
developed by Vásquez Quintero et al. [19]. Gold metallization sandwiched between 
layers of polyimide formed the wires and electrodes; after vias were opened to 
expose the electrode sites, the core device was encapsulated in TPU and moulded 
into a spherical cap shape. Four individually addressable microelectrode arrays 
were placed in the four quadrants of the lens, in order to monitor introduction, mixing 
and drainage of tear film from the lachrymal glands, across the surface of the eye, 
and out via the lachrymal puncta. In electrochemical tests the microelectrode arrays 
exhibited expected sensing characteristics when compared to a theoretical 
microdisc array, indicating that the fabrication method, the flexible substrate, 
encapsulation, moulding process and repeated mechanical deformation had no 
observable impact on the sensing performance of the device. In addition, the design 
of the ESCL, leading on from the results of Chapters 2 and 3, significantly increased 
the signal quality during high-speed chronoamperometry, with a reduction in 
parasitic capacitance, inductance and resistance, and the increased number of 
microdisc electrodes for each working electrode, greatly improving SNR. 
Experiments in a beaker, on a droplet and in a model eye demonstrated the ability of 
this device to perform real-speed spatiotemporal electrochemistry, measuring 
spatially disparate concentrations at a rate of ~ 20 Hz. In the model eye experiment, 
the introduction, progress and draining of high-concentration fluid was tracked at 
real-speed, with flow rates far greater than the maximum expected flow rates of the 
tear film, indicating the suitability of this ESCL for monitoring progress of the tear 
film in the eye. 
Future work may be carried out in developing the ESCL into a wireless device, 
improving comfort during use and overall utility. More working electrodes may be 
included to increase spatial resolution, and functionalised for various different 
biomarkers in order to investigate multiple processes in one device. This ESCL may 
also be used to investigate tear film flow in the eye when wearing a contact lens, 
something which is currently hard to measure accurately, and which information 




may inform future ESCL designs. With a wireless ESCL capable of spatiotemporal 
monitoring of analytes in the eye, measurements of real clinical utility may be made. 
  




7 Summary and Conclusions 
This chapter summarises the work detailed in this thesis, the key results and the 
significance of the findings within the field. Suggestions for further work are also 
presented, followed by some concluding remarks.  
7.1 Summary 
This work has addressed a number of fundamental issues facing ESCLs in current 
research. The primary goal of an ESCL – to take measurements non-invasively and 
continuously, and of real clinical utility – were previously undermined by various 
factors affecting the measurement, including uncertainty about the composition of 
the tear fluid being measured, performance of the electrochemical sensor, and 
disparity between the concentrations measured in the tear film versus that 
measured in the blood. The advances detailed in this work have offered solutions to 
each of these issues. 
Micro- (Chapter 3) and nanoelectrodes (Chapter 4) were investigated, with 
fabrication methods on flexible substrates developed for both types of sensor. 
Microelectrodes were deemed to be the most suitable for SCL integration. The 
development of spatially distributed microelectrode arrays, integrated for the first 
time into a soft, moulded SCL platform (Chapter 6), has increased sensing 
performance in comparison to the types of electrodes used in other ESCL 
prototypes, which are generally macroelectrodes of arbitrary physical form [3]. 
Microelectrodes have enhanced sensing properties such as better limit of detection, 
better signal to noise ratio (SNR) and shorter response time, all of which are 
important when carrying out measurements in the tear film – a dilute, low-volume 
medium undergoing continuous compositional change. Using microelectrode arrays 
allows control over the signal size of the working electrode, while preserving the 
enhanced sensing properties of the lens; previous work on ESCLs had not 
innovated with respect to the sensing properties of the working electrodes. 
Integrated into the neutral mechanical plane of the core polyimide substrate, and 
encapsulated in thermoplastic polyurethane, these microelectrode arrays have 
proven to be robust under expected use conditions such as full 180° folding, with 
sensing performance unchanged. Previous ESCL work has used PET [3] or silicone 
substrates [77] with issues of buckling [80], oxygen permeability, fabrication and 
user comfort. The ESCL presented in this thesis exhibits no buckling behaviour, is 




stretchable, mouldable, and allows oxygen flow into the surface of the eye, and 
represents a clear improvement on the previous state of the art [16]. 
To address the uncertainty surrounding the composition of the tear fluid, a new 
electrochemical technique has been developed. Using fast-switching 
chronoamperometry, the introduction, mixing, progress and drainage of tear fluid 
can be tracked at real-speed at multiple sites across the surface of the cornea. This 
technique was introduced in Chapter 3, and refined in Chapter 6 to produce 
electrochemical videos of an analyte flowing across a model eye. This new 
technique provides far more information about the nature of the sensing medium 
than any previous work, in which a single electrochemical sensor is operated on a 
continuous basis [3,77]. Using a single potentiostat, and a basic multiplexing unit, 
the physical requirements of the system are kept to a minimum, ensuring a path to 
facile integration into a wireless SCL system. Similarly, power requirements remain 
well within the safe limit deliverable to a SCL (Chapter 6), with a simple 
measurement protocol and the use of microelectrode arrays (which can draw far 
less current than macroelectrodes). 
The combination of the enhanced sensing properties of the advanced 
electrochemical sensors and the new electrochemical technique designed for this 
particular measurement challenge results in measurements of significantly greater 
clinical utility than the current state of the art. New tear fluid introduced at the 
lachrymal glands can be monitored before (and while) mixing into the bulk tear fluid 
in the eye. Subsequent analysis can produce a temporally accurate model of tear 
fluid composition, providing more information on the nature of the sensing medium 
than any other technique demonstrated in the literature. The data, after this retro-
analysis, therefore yields information about the concentration of the most recently-
introduced lachrymal fluid, reducing the time delay from concentration in the blood 
as much as possible, and reducing interference from environmental effects in the 
eye including evaporation, adulteration by other fluids such as rain or sweat, and 
drainage of the tear film via the lachrymal puncta or via tear formation. 
Finally, to correct for the remaining difference between the concentration of an 
analyte measured in the tear film, and the equivalent concentration in the blood, a 
neural network method has been developed. This process learns the particular 
mathematical correction of an individual patient, without assuming anything about 
the biomarker in question or even the type of measurement being undertaken. On 




simulated non-invasive data, the correction method improved the mean absolute 
normalised difference (MAND) versus the measured data from 46.9% to 4.8%, while 
the widely-used lag/bias model [7] achieved an improvement of only 46.9% to 21.2% 
This neural network method addresses the remaining step in producing data of real 
clinical utility from measurements made in the tear film. 
The result of these three primary advances in ESCL technology, and the various 
secondary improvements made on previous state-of-the-art prototypes, is to create 
a blueprint for a complete system capable of continuous, non-invasive and 
unobtrusive measurement, capable of measuring multiple biomarkers 
simultaneously for a wide range of diagnostic applications, and performing 
measurements of sufficient quality to help draw meaningful diagnostic conclusions in 
a clinical setting. There is a number of exciting applications for this technology, 
including investigation into processes which cannot yet be satisfactorily monitored: 
e.g. the variations of salts and sugars in a person’s body during normal day-to-day 
activities, exercise or ultramarathons; the spiking of cortisol in a firefighter’s 
bloodstream as they perform hazardous tasks; dopamine and serotonin in an 
expecting mother, or even while giving birth; or a complete measurement of the 
endocrine system as a patient trials a new anti-depressant medication. This 
technology offers a window into a world we have only just started to explore.  
7.2 Further Work 
The use of this ESCL has been demonstrated in a wired device, on a model eye. 
There is therefore a number of clear advances to be made at this stage. 
7.2.1 Development of Analogue Front-End Electronics 
CMOS implementation of analogue electronics designed to harvest power from an 
inductive source, drive electrochemical measurement and communicate data has 
been demonstrated in previous work [3]. Integration of thinned silicon circuits into 
the polyimide/TPU platform has also been demonstrated [19]. An ESCL device 
suitable for clinical trials would benefit from development of a bespoke CMOS 
implementation of the spatiotemporal electrochemical measurement architecture. 
The requirements of this function are similar to implementations found in previous 
work (signal conditioning, a potentiostat unit, etc); the primary addition is an 
analogue multiplexing module, used to switch sequentially between working 
electrodes. 




7.2.2 Development of Wireless Capability 
Integration of wireless capability into this ESCL would enable comfortable use in live 
animals or humans. Therefore, the development of wireless capability should be a 
key focus. Wireless function of an ESCL has already been demonstrated, with an 
on-board chip containing signal conditioning and potentiostat functions, and an 
antenna for both wireless power and data transfer [3]. Following this established 
work, and other similar designs in SCLs, it only remains to design a custom chip to 
carry out the fast-switching chronoamperometry algorithm, and similar power 
conditioning and signal processing functions. Integration of the chip, design of the 
antenna, and the periphery devices has already been demonstrated, and these 
methods can be adapted to this device [19]. 
7.2.3 Refinement of the Placement of Working Electrodes 
A refinement of the microelectrode array design may improve the sensing properties 
of the system. In Chapter 3 the fast-switching chronoamperometry technique was 
demonstrated with eight working electrodes, while the final ESCL design in Chapter 
6 only used four. It would therefore be a simple task to integrate more working 
electrodes into the SCL platform – up to eight and likely more. Positioning of each 
electrode may also be refined. While an electrode array was placed in each 
quadrant in the final ESCL device (Figure 7.1 a), analysis of the tear film flow may 
be improved by placing more electrode arrays in the region near the lachrymal ducts 
(Figure 7.1 b), to better monitor ingress of new tear fluid. The physical design of the 
ESCL, and particularly the electrode placement, may require iterative optimisation, 
i.e. using a current ESCL design to better understand the flow characteristics of the 
tear film and thus inform the next generation of design. 





Figure 7.1: Possible refinement of the working electrode placement. (a) The 
current design, with a working electrode in each quadrant of the lens. (b) A 
possible future design, in which a cluster of working electrodes near the 
lachrymal glands monitors introduction of new tear fluid, and others are 
placed to take measurements in the lachrymal lake at the lower eyelid, and 
by the lachrymal puncta. Parts of this figure reproduced from Gray's Anatomy, 
Plate 896. 
7.2.4 Functionalisation of the Working Electrodes and Clinical Testing 
With a wireless device, testing in an animal or human subject would be possible with 
minimal irritation to the wearer. Building on established SCL designs which have 
been approved for clinical use, an optimised, wireless and safe ESCL could be built 
and the flow characteristics of the tear film may be investigated. Next, 
functionalisation of the working electrodes to select for different biomarkers may be 
developed. There exist already established chemical methods to functionalise an 
electrode for various biomarkers such as glucose, lactate and cortisol, which may be 
adapted to this device. Functionalisation could be carried out in bulk (across the 
whole device) or with more precision using inkjet printing methods. If multiple 
biomarkers are measured on one ESCL, differential or multimodal use may improve 
diagnoses, measurement fidelity, and cost efficiency of a device. In the design 
described in Chapter 6 an external reference electrode was used, but on-board 
reference electrodes have been demonstrated for ESCL designs [1], and, since they 
are used in common with each electrode, would not increase design footprint 
significantly. 




7.2.5 Safe Encapsulation of the ESCL 
Partial and full hydrogel encapsulations are both possible. For a partial 
encapsulation, the active side of the ESCL may be left exposed to allow for tear film 
contact; for a full encapsulation, analyte diffusion through the hydrogel may be 
sufficient for electrochemical sensing, or active functionalised hydrogels may be 
used to avoid the need to rely on diffusion [92]. Direct windows to the sensing sites 
may be created in the hydrogel, akin to those in the TPU top layer of the device 
described in Chapter 6. Alternatively, channels could be etched into the hydrogel to 
provide flow access to the sensors, perhaps with a passive blink-mediated pumping 
system to improve fluid transport (similar to musculovenous pumping) [91]. 
However, irritation might occur at the window or channel sites, and biofouling could 
result in significant flow problems. 
7.2.6 Skin-based Sensing with the Nanoband Mesh Electrode 
Beyond the ESCL itself, further development of the nanoelectrode devices 
described in Chapter 4 may be of interest. Although the through-flow architecture is 
not necessarily suitable for an ESCL, it may be of great utility to skin-based sensing. 
Skin-based electrochemical sensing has suffered from issues with sweat pooling – 
i.e. uncertainty about the composition of sweat from various points in time being 
mixed together in the sensing region (an analogous problem to that found in the tear 
film, which was addressed with the spatiotemporal sensing method). Planar sensors 
either trap sweat underneath the device, or wait for sweat to arrive on top of the 
device, both of which leads to great uncertainty in measurements. The through-flow 
nanoband mesh sensors, combined with a wicking fabric on top, would draw sweat 
through the sensing regions (the channels) and measure concentrations of 
biological markers during fluid transport. The sweat would subsequently be drawn 
away by the wicking fabric. This would ensure measurements are taken in only the 
most recently produced sweat, and unmixed with older sweat. The nanoband design 
of the sensors leads to extremely fast sensing capabilities, and the fabrication 
method allows for arbitrary 2-D designs to be created, for optimum conformation to 
skin and integration into devices. Future work may therefore develop the physical 
shape and functionalisation of these sensors to achieve non-invasive, continuous 
sensing in sweat. 




7.2.7 Monitoring of Flowing Fluids 
The active monitoring of flowing fluids described in Section 4.4 by the nanoband 
mesh devices may be further developed to cater for specific cases, such as 
monitoring of fluid concentrations in automated industrial fabrication facilities and 
water monitoring or purification. The electrochemical methods used to achieve this 
require further development to ensure measurement quality, and optimisation of the 
physical aspects of the nanoband mesh, such as pore size and design of the 
counter and reference electrodes, is also necessary. 
7.2.8 Improvements to the Neural Network Method 
The neural network method described in Chapter 5 may be developed further in a 
number of ways. First, by improving the method itself, such as increasing the 
resolution of the network to avoid averaging errors, increasing the number of 
neurons, or adding layers (to create a ‘deep neural network’). Next, integration of 
covariate data into the method – e.g. allowing the network to analyse glucose data 
as well as cortisol data to establish corrections with respect to interactions or 
correlations between the two data sets. In a simple implementation, the covariate 
data sets (i.e. a number of additional time-series concentration data sets from 
monitoring of other covariate species) may simply be added to the neural network at 
the input neuron layer, and co-interactions allowed to establish themselves via 
iterative training as before. Finally, in the future, the generation of real non-invasive 
data sets, paired with concurrent measurement in the blood, will allow testing and 
refinement of this neural network method on real data. 
7.3 Concluding Remarks 
This work, culminating in a new ESCL architecture, new sensing methodology and 
new signal processing methods, advances the state of the art in ESCLs and 
wearable devices in general. Having utilised fabrication methods, technologies and 
materials with established biocompatibility and safety in other medical devices, there 
now exists a clear route to clinical utility for this device. With the potential for truly 
non-invasive, continuous, unobtrusive sensing, this ESCL could advance our 
understanding of a wide array of different conditions, and help change the way we 
approach healthcare and medicine. 
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9.2 Additional Test Sets (Chapter 5)  
































Simulated Data: Neural Network Reconstruction 
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